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Preface
This study was conducted to provide new knowledge pertinent to the acute phase protein,
amyloid A (AA) in the peripartum and neonatal period. Hepatic derived serum AA is an
acute phase protein in the horse. Its serum concentration increases with inflammation or
infection but its function has not yet been fully elucidated. We evaluated the specificity
of serum AA as an indicator of neonatal sepsis elaborated various other influences on the
serum concentration of this protein in foals. A mammary derived isoform of AA has been
discovered and is believed to have protective effects in the neonatal intestine. We
identified this protein in equine colostrum and milk and investigated its potential
intestinal absorption in neonatal foals. We also investigated the effect of other parturient
events including induction of parturition on AA concentration in mares. This study
analyzed the effect of a new, safer method of induction of parturition in the mare on the
neonatal acute phase response. Specific objectives of this research were to a) assess
hepatic derived AA as an indicator for sepsis in the neonatal foal; b) quantify mammary
derived AA in equine colostrum and milk; c) assess whether intestinal absorption of
mammary derived AA could affect neonatal serum concentrations of the protein and d)
assess whether induction of parturition affected neonatal serum concentrations of this
protein.
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1CHAPTER I
INTRODUCTION
2Assays for acute phase proteins are currently being developed in different domestic
animal species as a tool to assess animal health. An acute phase protein has been defined
as one whose plasma concentration increases (positive acute-phase protein) or decreases
(negative acute-phase protein) by at least 25 percent during inflammatory disorders. This
response is non-specific in that serum concentrations of these proteins change during
inflammatory disorders of all kinds, infectious or non-infectious.
Research has focused, however, on the use of a hepatic-derived acute phase protein,
serum amyloid A (AA), as an aid in the differential diagnosis of weak neonatal foals. It
has been claimed that concentrations of this protein rise during bacterial infection to
levels that are significantly higher than those reached during non-infectious inflammatory
conditions.
It is questionable whether measurement of serum AA is truly a specific indicator of
equine neonatal sepsis and needs further investigation. Many other non-infectious
sources of amyloid A (AA) may complicate the picture. Recent research has also detected
a mammary gland derived isoform of the acute phase protein, AA, in the colostrum and
early milk of women, cows and ewes and in the colostrum of one mare. It has not been
determined whether amyloid A is present in the colostrum and early milk of all mares.
Foals absorb macromolecules from the intestine during the early post partum period,
making absorption of mammary derived amyloid A from the colostrum likely to interfere
with interpretation of serum concentrations of this protein in the diagnosis of sepsis. The
mammary derived AA protein has been shown to have protective effects in the neonatal
intestine of infants and calves. If it is present in large quantities in the mammary
secretions of healthy mares, its function in the neonatal intestine and/or extra-intestinal
3tissues in the neonatal foal also warrants investigation but is outside the scope of this
study (see Chapter 4).
Other peri-partum factors may also affect the concentration of serum AA in neonatal
foals. Induction of parturition in the mare has been traditionally avoided due to concerns
about complications such as dystocia, retained placenta and birth of a compromised foal.
However, there have been advances in the techniques used to induce mares to foal. If
induction of parturition in the mare compromises the neonatal foal and causes an
inflammatory response beyond that seen secondary to natural parturition, this should be
detectable in the postpartum serum AA profile of the foal and may lead to elevation of
the serum AA concentration for reasons unassociated with sepsis. Acute phase protein
concentrations in neonatal foals that have been induced have never been examined to
establish the validity of concerns about compromising foals by inducing parturition.
The purpose of these studies was to investigate the specificity of serum AA measurement
as a indicator of sepsis in the neonatal foal; to document the presence of AA in the
colostrum and early milk of a large group of mares; to investigate whether the neonatal
serum concentration of this protein could be influenced by intestinal absorption of AA
from colostrum and early milk and to investigate the influence of induction of parturition
on serum AA concentration in the neonatal foal.
4CHAPTER II
REVIEW OF LITERATURE
5Acute phase proteins
The systemic inflammatory response follows tissue damage or infection. It involves
changes in a number of organ systems, many distant to the site of tissue damage, in an
attempt to restore homeostasis (1). Acute phase protein concentrations in the plasma rise
as part of this response (1). The term “acute-phase” was first used in this context in 1941
to describe serum in which a protein was found that was not normally present (2). An
acute phase protein (APP) has been defined as one whose plasma concentration increases
(positive acute-phase protein) or decreases (negative acute-phase protein) by at least 25
percent during inflammatory disorders (3). The acute phase response is a non-specific
systemic response and occurs with acute and chronic inflammation of any kind (3).
Conditions that induce increases in plasma concentrations of acute phase proteins in
humans include infection, trauma, surgery, burns, tissue infarction, immune-mediated
disease, cancer, strenuous exercise, heatstroke and childbirth (3).
The pathophysiology behind the increased plasma concentrations of APPs in response to
inflammation involves a cascade of interactions between intracellular messengers. Tissue
damage leads to the release of cytokines from activated cells into the blood stream (1).
Most cytokines have multiple targets and functions and they may be inhibited or
enhanced by other cytokines (3). They may also be influenced by hormones and by
cytokine-receptor antagonists and circulating receptors (3).
Cytokine messengers stimulate cells to synthesize inflammatory proteins. APPs are
primarily synthesized in the liver (1). There are essentially two families of APPs. Type I
APPs, serum AA and C-reactive protein (CRP), are induced by Interleukin 1 (IL1) and
Tumor Necrosis Factor (TNF), and Type II APPs, fibrinogen and haptoglobin, are
6induced by Interleukin 6 (IL6) (1). Once synthesized, the APPs are released into the
circulation to exert their effect.
APPs are part of the innate immune response and have several important functions
including homeostasis, opsonization and trapping of micro-organisms and their products,
activating complement, bacterial phagocytosis, decreased thrombosis, decreased
proteolysis and antioxidants, neutralizing enzymes, scavenging free hemoglobin and
radicals, and in modulating the host’s immune response (1,4). However, the function of
each individual APP has not been clearly determined.
A delay of several hours is intrinsic to the cascade of interactions which lead to elevation
of serum APP levels (5). In other words, the time interval from the initial damage and
activation of cytokine-secreting cells to the initiation of hepatic APP synthesis is
responsible for the significant lag phase required until elevated serum APP exacerbations
become measurable. Therefore, multiple serial concentration measurements give a better
picture of the ongoing inflammatory process than one single concentration measurement
at the onset of illness.
The acute phase response is highly variable and non-specific; the increase in serum
concentration of these inflammatory proteins depends on the severity of infection or
tissue damage, the stage of the disease, the interaction of the cascade of cytokines and the
individual response to the disease. Bacterial infection and severe cellular destruction
stimulate greater responses than does viral infection (4). It is thought that assessment of
an index of various positive and negative APPs over time gives a markedly more
sensitive and specific indication of the extent and stage of the disease process than a
single measurement of a single protein at one time point (4, 5). Once therapy has been
7initiated and /or the immunological response of the host has successfully contained the
initial insult, the stimulus for new synthesis of APP is eliminated. Thereafter,
concentrations are mostly a function of the half-life of the proteins and return to base
level (4) unless there is persistence of the insult, e.g. from disseminated abscesses in
various organs.
Acute phase proteins in Veterinary Medicine
APP concentrations in different veterinary species are used as markers of animal health
(6, 7). Health problems of pigs have been shown to be correlated with increases in
haptoglobin, CRP and ceruloplasmin (6). In cattle, a strong reproducible rise in serum
AA and haptoglobin is seen following experimental infection with bovine respiratory
syncytial virus (6). APPs are also thought to be useful as a tool in evaluating health in
calf herds (8). Physical stress has been demonstrated to significantly increase serum AA
concentrations in calves without a significant difference in cortisol or aldolase
concentrations. Therefore, serum AA is suggested as a sensitive variable for assessing
physical welfare in calves (9). In cats, serum AA, alpha 1 acid-glycoprotein and
haptoglobin are measureable APPs (10). Ceruloplasmin and CRP concentrations were
shown to be elevated in dogs with babesiosis compared with unaffected dogs (11).
However, as is the case in humans, the acute phase response in animals is highly variable
between individuals and dependent on stage and severity of disease. In cattle, it is
suggested that the ability to produce serum AA and haptoglobin may be an innate
characteristic of the individual cow, because APP concentration responses to
lipopolysaccharide differed significantly among cows (12). In a study in dogs, where
CRP and ceruloplasmin were consistently elevated in leishmaniosis at the time of
8diagnosis, the serum AA concentration of some of the dogs remained within the normal
range (13). Indices of various APPs over time have been used in the assessment of health
in cattle and pigs (14, 15).
Equine acute phase proteins
Fibrinogens, serum AA, alpha 1 acid glycoprotein (a1AGP), CRP, haptoglobin and
ceruloplasmin have been proposed as APPs in horses (16). In horses, serum AA appears
to be the major APP with the earliest response to inflammatory stimuli (17). Alpha 1AGP
appears to be the next to rise (18), followed in succession by CRP (19), haptoglobin (20)
and fibrinogen (21). These latter proteins are minor acute phase proteins in the horse.
Ceruloplasmin is slow to rise in the serum following inflammatory stimuli and may be a
delayed minor acute phase protein in the horse (22).
Equine Serum Amyloid A
The dynamics of serum AA in the horse have been described. The average serum AA
concentration of normal adult horses (>18 months old) is 21 +/- 9 mcg/ml (16). After
induced non-infectious inflammation, the serum AA concentration rises above baseline
by 16 hours post inflammatory stimulus and peaks at 36-48 hours at 227 times baseline
(23). Elective surgery in horses resulted in a 164-fold increase in serum AA
concentrations by 24 hours post surgery, whereas non-elective surgery resulted in a 273-
fold increase by 24 hours post surgery (24). Horses with equine influenza virus infection
had a rise in serum AA concentrations over the first 48 hours with the concentration
returning to baseline by 11-22 days in uncomplicated cases (25). Horses with bacterial
infections such as Streptococcus equi abscesses had serum AA concentration increases of
up to 800-fold (17).
9There is a distinct overlap in the ranges of serum AA concentrations resulting from
different types of inflammation; however, this is consistent with the nonspecific nature of
the serum AA response (26). For this reason serum AA is deemed to be a sensitive but
nonspecific marker for inflammation.
Serum amyloid A in neonatal foals
In normal neonatal foals, there is a mild increase in serum AA concentration in the period
immediately after birth, and it remains relatively high for 1 week (16). Serum
concentrations of APPs are known to increase several hundredfold in response to
bacterial infection in human infants and are routinely used in human medicine in the
differential diagnosis of sepsis in infants (27-31). Research has shown that the
measurement of serum AA can be a useful diagnostic tool in the differentiation of sepsis
from other conditions in neonatal foals (32).
Bacterial sepsis is a challenging diagnosis in neonatal medicine. Neonates of all species
are at increased risk of developing infection probably due to the immaturity of the
neonatal immune system. Although equine neonates are immunocompetent at birth, they
are particularly at risk for infection given the epitheliochorial nature of equine
placentation and the lack of placental transfer of immunity.
Sepsis occurs most commonly in the foal in the first 48 hours of life, and the modes of
infection are intrauterine, oral, and respiratory, via umbilical cord or traumatic
penetration of the skin (33). The organisms establish infection in the entry organ.
Bacteria and their toxins then invade the blood stream causing damage to endothelium
and the release of cytokine mediators that initiate the systemic inflammatory response
and the production of acute phase proteins.
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In a study measuring serum AA as an aid to differential diagnosis of infection in newborn
foals, foals suffering from weakness, neonatal maladjustment syndrome, traumatic birth
or meconium colic had significantly higher concentrations than did controls (32). In fact,
clinical cases of infection had significantly higher concentrations than did the other
groups. In another study, serum AA was compared with total leukocyte count, neutrophil
count and fibrinogen as an aid in the management of infectious disease in the foal.
Results indicated that serum AA might be an aid in the differential diagnosis of neonatal
weak foals (34). Serum AA and fibrinogen concentrations on admission were higher in
foals with bacterial infections than in foals with nonbacterial or uncertain diagnoses.
Foals with positive blood cultures had markedly increased serum AA and fibrinogen
concentrations and varying leukocyte concentrations.
Other sources of AA may complicate the interpretation of serum AA concentrations in
neonatal foals. The placenta is capable of producing cytokines, such as TNF alpha and
interleukins in response to hypoxia and endotoxin stimulation (35-38). Placental
umbilical vascular disease results in increased IL6 and IL8 concentrations in human fetal
circulation (39, 40). It is possible, therefore, that perinatal events, such as placentitis or
placenta previ, could induce an inflammatory response in the fetal foal. Twins that are
carried full term are uncommon in mares. However, when this does occur, the foals often
share a large area of the placentation, which can cause compromise and potentially
induce an inflammatory response.
As twin foals and foals from mares with placental disease are typically compromised and
prone to secondary sepsis, it may be a moot point as to the source of the circulating AA;
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however, it is useful to elaborate the various sources of neonatal AA production
stimulation.
Acute phase proteins such as haptoglobin, a1AGP and ceruloplasmin have been
demonstrated in the colostrum and milk from several species (41-43) and some have been
demonstrated to cross the placenta (42, 44, 45). In the neonatal foal, large proteins are
absorbed intact as functional proteins across the intestinal wall (46,47). Absorption is
maximal at about 6 hours after the milk is ingested, but increased permeability to
macromolecules persists for up to 24 hours. To date, however, there are no studies on the
intestinal transfer of colostral or milk APPs in mares, and it seems likely that such
colostral proteins are absorbed.
Amyloid A in the broodmare
A major acute phase response involving serum AA has been demonstrated from onset of
labor to 96 hours post partum in normal women; however a wide range of concentrations
are seen (48). In cattle, serum AA concentrations increase significantly from pre-
parturient concentrations in the first 24 hours post partum, reaching a peak 24 to 48 hours
after delivery (49). In the post-parturient mare, serum AA concentration peaks at on
average 137mcg/ml 3 days post partum but a wide concentration range occurs (16).
An isoform of AA was recently identified in the colostrum and early milk from women,
cows, ewes, sows and one mare (41). This colostral and milk isoform, called milk AA, is
produced by healthy animals, synthesized in mammary gland cells not in the liver,
expressed by mammary gland epithelial cells and secreted in abundance as part of a
normal process (41).
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In cows with mastitis, AA is also elevated (50). It appears that AA accumulation in
mastitic bovine milk is the result of both local synthesis of AA and transfer of
hepatically-derived serum AA to the milk due to increased permeability of the blood-milk
barrier. In the mare, only one isoform of AA, the mammary derived isoform, has been
detected in colostrum (A Weber, personal communication), which is not unusual given
the infrequent occurrence of clinical mastitis in mares.
Colostrum has received renewed interest over recent years due to the many bioactive
substances it contains (51-57). Bovine colostrum in particular is promoted for the
treatment of many human conditions due to the high concentration of immuno-globulins,
growth factors, cytokines, and nucleosides that are found in it (51). These hormones and
regulatory factors in colostrum and milk may have roles in the development and
maintenance of neonatal tissues including but not limited to the neonatal intestine (51-
56).
Mares synthesize and secrete on average 5 liters of colostrum. There have been limited
studies on the regulatory and growth factors in mares’ colostrum or milk (57-60). The
milk AA protein was demonstrated in the colostrum of only one mare (41). However,
researchers believe that this milk AA can prevent necrotizing enterocolitis in human
infants. Milk AA enhances the innate immunity of the human and bovine neonatal
intestines by up-regulating mucin production and by preventing the attachment of
pathogenic E coli to intestinal cells (61, 62). It is likely that similar functions may be
attributed to this equine colostrum and milk protein with respect to the equine neonatal
intestine.
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Necrotizing enterocolitis
Necrotizing enterocolitis is an intestinal disorder that frequently affects compromised
neonatal foals and has a high case mortality risk (63-66). Necrotizing enterocolitis
(NEC) is a multifactorial problem, and also represents the most common gastrointestinal
emergency in human neonates (67). Despite extensive research, its etiopathogenesis is
not completely understood and this neonatal disease remains associated with high
morbidity and mortality rates. The intestinal injury in this disease may be a consequence
of prematurity, hypoxia, enteral feeding and bacterial colonization (68). Together these
factors can result in an exaggerated inflammatory response, leading to ischemic bowel
necrosis.
Human milk constituents, including milk AA, may decrease the incidence of NEC by
decreasing pathogenic bacterial colonization, promoting growth of nonpathogenic flora,
promoting maturation of the intestinal barrier, and ameliorating the pro-inflammatory
response (69).
Unfortunately, many equine neonatologists promote the withdrawal of enteral feeding
from compromised neonates to avoid overloading the intestine with rich ingesta which
may promote bacterial colonization. Withdrawal of enteral feeding in compromised foals,
however, may result in restriction of access of the beneficial components of colostrum to
the patients that are in most need of them. Unfortunately, there has been limited research
in this field in the mare.
Induction of parturition
Induction of parturition with its associated complications has the potential to produce
elevated serum AA concentrations in neonatal foals. Traditionally there were few
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clinical indications for induction of parturition in the mare, because it has been associated
with increased incidence of peri-partum complications such as dystocia and with
unfavorable outcome in foals (70-72). However, it has recently been proposed that
induction of parturition in mares at term with low doses of oxytocin is a safe and reliable
way to induce parturition (73). Three main methods are described for induction of
parturition in mares using oxytocin, prostaglandin F2 alpha and dexamethasone.
Oxytocin is generally considered the drug of choice in that small doses of oxytocin (2.5–
10 i.u.) are effective at successfully triggering parturition at term, and higher doses (40-
120 i.u.) used to induce birth in previous studies are unnecessary and potentially
dangerous to the fetal foal (73, 74). Low doses of 2.5-5 i.u. cause a slow progression
toward delivery; higher doses evoke a more rapid delivery response. However, this low
dose method of induction can override the physiologic events involved in normal
parturition without considering fetal maturity (73). Therefore, parturition must be
pending when the mare is induced.
Calcium concentrations in the mammary secretions have been shown to be useful in
predicting full-term gestation and are commonly used to predict impending parturition
(75). When the pre-foaling mammary secretion calcium carbonate equals or exceeds 200
ppm, there is a 51% probability that spontaneous foaling will occur within 24 hours, an
84% probability that it will occur within 48 hours and a 97% probability that foaling will
occur within 72 hours (73). When a concentration of 300-500 ppm is reached, the
majority of mares will foal within a short period of time (24 hours); however, not all
mares reach this concentration before foaling. Administration of low doses of oxytocin to
full term mares with calcium concentrations >200 ppm in the mammary gland secretions
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for at least 24 hours is now considered an effective method of induction of parturition
(73).
Several studies have examined various parameters in the neonatal foal with regard to
induction of parturition (71, 75-77). In one early study describing the induction of mares
with a synthetic prostaglandin, four of eleven foals from mares that were induced did not
survive the first 24 hours (71). Although much is now known about how inducing drugs
affect the mare, and methods of induction have been refined from earlier protocols which
were associated with violent expulsion of a frequently premature foal, we are unaware of
any published studies that directly address the influence of induction of parturition on the
production of an inflammatory or acute phase response in the foal.
16
References
1. Bistrian BR. Acute phase proteins and the systemic inflammatory response. Crit
Care Med 1999. 27(3):452-455
2. Abernethy TJ. Avery OT. The occurrence during acute infections of a protein not
normally present in the blood. 1 Distribution of the reactive protein in patients
sera and the effect of calcium on the flocculation reaction with C polysaccharide
of Pneumococccus. J Exp. Med. 1941; 73: 173-182
3. Gebay C, Kushner I. Acute-phase proteins and other systemic responses to
inflammation. The New England Journal of Medicine. 1999; 30(6):448-453
4. Gruys E, Toussaint MJ, Niewold TA, Koopmans SJ. Acute phase reaction and
acute phase proteins. Review. J Zhejiang Univ Sci B. 2005 Nov; 6(11):1045-56.
5. Benitz WE, Han MY, Madan A, Ramachandra P. Serial serum C-reactive protein
levels in the diagnosis of neonatal infection. Pediatrics. 1998 Oct; 102 (4):E41
6. J Gordon Skinner. International Standardization of Acute Phase Proteins: Special
Report; Veterinary Clinical Pathology 2001; 30(1):2-7 
7. Petersen HH, Nielsen JP, Heegaard PM. Application of acute phase protein
measurements in veterinary clinical chemistry. Vet Res. 2004 Mar-Apr;
35(2):163-87. Review.
8. Ganheim C, Alenius S, Persson Waller K. Acute phase proteins as indicators of
calf herd health. Vet J. 2006 Mar 16
9. Alsemgeest SP, Lambooy IE, Wierenga HK, Dieleman SJ, Meerkerk B, van
EderenAM, Niewold TA. Influence of physical stress on the plasma concentration
17
of serum amyloid-A (SAA) and haptoglobin (Hp) in calves. Vet Q. 1995 Mar;
17(1):9-12
10. Kajikawa T, Furuta A, Onishi T, Tajima T, Sugii S. Changes in concentrations of
serum amyloid A protein, alpha 1-acid glycoprotein, haptoglobin, and C-reactive
protein in feline sera due to induced inflammation and surgery. Vet Immunol
Immunopathol. 1999 Mar 29; 68(1):91-8 
11. Ulutas B, Bayramli G, Ulutas PA, Karagenc T. Serum concentration of some
acute phase proteins in naturally occurring canine babesiosis: a preliminary study.
Vet Clin Pathol. 2005 Jun; 34(2):144-7 
12. Jacobsen S, Andersen PH, Toelboell T, Heegaard PM. Dose dependency and
individual variability of the lipopolysaccharide-induced bovine acute phase
protein response. J Dairy Sci. 2004 Oct; 87(10):3330-9 
13. Martinez-Subiela S, Bernal LJ, Ceron JJ. Serum concentrations of acute-phase
proteins in dogs with leishmaniosis during short-term treatment. Am J Vet Res.
2003 Aug; 64(8):1021-6 
14. Toussaint MJM, van Ederen AM, Gruys E. Implication of clinical pathology in
assessment of animal health and in animal production and meat inspection. Comp
Haematol Internat. 1995; 5:149–157
15. Toussaint MJM, Eckersall PD, Alava M, Madec F, Meloen RH, Gruys E. Acute
phase protein assays as tool in assessment of health in pigs. Proc. ISACB
congress Toulouse. Rev Vet Med. 2000; 151:780.
18
16. Nunokawa Y, Fujinaga T, Taira T, Okumura M, Yamashita K, Tsunoda N, Hagio
M. Evaluation of Serum Amyloid A protein as an acute phase reactive protein in
horses. J Vet Med Sci 1993; 55:1011-1016
17. Pepys MB, Baltz ML, Tennent GA, Kent J, Ousey J, Rossdale PD. Serum
amyloid A protein (SAA) in horses: objective measurement of the acute phase
response. Equine Vet J. 1989 Mar; 21(2):106-9
18. Taira T, Fujinaga T, Tamura K, Izumi M, Itoh H, Tsunoda N, Yamashita K,
Okumura M, Mizuno S al. Isolation and characterization of alpha 1-acid
glycoprotein from horses, and its evaluation as an acute-phase reactive protein in
horses. Am J Vet Res. 1992 Jun; 53(6):961-5 
19. Yamashita K, Fujinaga T, Okumura M, Takiguchi M, Tsunoda N, Mizuno S.
Serum C-reactive protein (CRP) in horses: the effect of aging, sex, delivery and
inflammations on its concentration. J Vet Med Sci. 1991 Dec; 53(6):1019-24
20. Taira T, Fujinaga T, Okumura M, Yamashita K, Tsunoda N, Mizuno S. Equine
haptoglobin: isolation, characterization, and the effects of ageing, delivery and
inflammation on its serum concentration. J Vet Med Sci. 1992 Jun; 54(3):435-42
21. Allen B.V. and Kold S. E. Fibrinogen response to surgical tissue trauma in the
horse. Eq Vet J 1988. 20: 441-443
22. Okumura M, Fujinaga T, Yamashita K, Tsunoda N, Mizuno S. Isolation,
characterization, and quantitative analysis of ceruloplasmin from horses. Am J
Vet Res. 1991 Dec; 52(12):1979-85
19
23. Hulten C. Dynamics in serum of the inflammatory markers serum amyloid A
(SAA), haptoglobin, fibrinogen and alpha2-globulins during induced
noninfectious arthritis in the horse. Eq Vet J 2002; 34:699-704
24. Pollock PJ, Prendergast M, Schumacher J, Bellenger CR. Effects of surgery on
the acute phase response in clinically normal and diseased horses. Vet Rec 2005;
156:538-42
25. Hulten C, Sandgren B, Skioldebrand E, Klingeborn B, Marhaug G, Forsberg M.
The acute phase protein serum amyloid A (SAA) as an inflammatory marker in
equine influenza virus infection. Acta Vet Scand. 1999; 40(4):323-33
26. Hulten C, Tulamo RM, Suominen MM, Burvall K, Marhaug G, Forsberg M. A
non-competitive chemiluminescence enzyme immunoassay for the equine acute
phase protein serum amyloid A (SAA) -- a clinically useful inflammatory marker
in the horse. Vet Immunol Immunopathol. 1999 May; 68(2-4):267-81
27. Pizzini C, Mussap M, Plebani M, Fanos V. C-reactive protein and serum amyloid
A protein in neonatal infections. Scand J Infect Dis. 2000; 32(3):229-35 Review.
28. Ewerbeck H, Kunzer W, Uhlig T. Serum C-reactive protein in early diagnosis of
bacterial infections in premature infants. Acta Paediatr Hung. 1984; 25(1-2):55-8 
29. Forest JC, Lariviere F, Dolce P, Masson M, Nadeau L. C-reactive protein as
biochemical indicator of bacterial infection in neonates. Clin Biochem. 1986 Jun;
19(3):192-4 
30. Arnon S, Litmanovitz I, Regev R, Bauer S, Lis M, Shainkin-Kestenbaum R,
Dolfin T. Serum amyloid A protein is a useful inflammatory marker during late-
20
onset sepsis in preterm infants. Biol Neonate. 2005; 87(2):105-10. Epub 2004
Nov 9
31. Arnon S, Litmanovitz I, Regev R, Lis M, Shainkin-Kestenbaum R, Dolfin T. The
prognostic virtue of inflammatory markers during late-onset sepsis in preterm
infants. J Perinat Med. 2004; 32(2):176-80
32. Chavatte PM, Pepys MB, Roberts B. et al Measurement of Serum Amyloid A
protein (SAA) as an aid to differential diagnosis of infection in newborn foals. In
Equine Infectious Diseases Vol 6, Proceedings of the Sixth International
Conference, 1992; Eds: W Plowright, PD Rossdale and JF Wade, R&W
Publications, Newmarket, pp33-38
33. Paradis MR. Update on neonatal septicemia. Vet Clin North Am Equine Pract.
1994 Apr; 10(1):109-35. Review.
34. Hulten C, Demmers S. Serum Amyloid A (SAA) as an aid in the management of
infectious disease in the foal: comparison with total leukocyte count, neutrophil
count and fibrinogen. Eq Vet J 2002; 34: 693-698
35. Benyo DF, Miles TM, Conrad KP. Hypoxia stimulates cytokine production by
villous explants from the human placenta. J Clin Endocrinol Metab. 1997 May;
82(5):1582-8 
36. Shimoya K, Moriyama A, Matsuzaki N, Ogata I, Koyama M, Azuma C, Saji F,
Murata Y. Human placental cells show enhanced production of interleukin (IL)-8
in response to lipopolysaccharide (LPS), IL-1 and tumour necrosis factor (TNF)-
alpha, but not to IL-6. Mol Hum Reprod. 1999 Sep; 5(9):885
21
37. Bowen RS, Gu Y, Zhang Y, Lewis DF, Wang Y. Hypoxia promotes interleukin-6
and -8 but reduces interleukin-10 production by placental trophoblast cells from
preeclamptic pregnancies. J Soc Gynecol Investig. 2005 Sep; 12(6):428-32
38. Conrad KP. Benyo DF. Placental cytokines and the pathogenesis of preeclampsia.
Am J Reprod Immunol. 1997 Mar; 37(3):240-9. Review.
39. Trudinger B, Wang J, Athayde N, Beutler L, Wang X. Association of umbilical
placental vascular disease with fetal acute inflammatory cytokine responses. J Soc
Gynecol Investig. 2002 May-Jun; 9(3):152-7 
40. Wang X. A proinflammatory cytokine response is present in the fetal placental
vasculature in placental insufficiency. Am J Obstet Gynecol. 2003 Nov;
189(5):1445-51.
41. McDonald TL, Larson MA, Mack DR, Weber A. Elevated extra hepatic
expression and secretion of mammary-associated serum amyloid A 3 (M-SAA3)
into colostrum. Vet Immunol and Immunopathol. 2001; 3: 203-211
42. Schroedl W, Jaekel L, Kreuger M. C-reactive Protein and antibacterial activity in
blood plasma of colostrums-fed calves and the effect of lactulose. J Dairy Sci.;
2003: 86:3313-3320.
43. Ceciliani F, Pocacqua V, Provasi E, Comunian C, Bertolini A, Bronzo V, Moroni
P, Sartorelli P. Identification of the a-1 acid glycoprotein in colostrum and milk.
Vet Res. 2005 Sep-Dec; 36(5-6):735-46
44. Talukder MJ, Takeuchi T, Harada E. Transport of colostral macromolecules into
the cerebrospinal fluid via plasma in newborn calves. J Dairy Sci. 2002 Mar;
85(3):514-24
22
45. Harada E, Araki Y, Furumura E, Takeuchi T, Sitizyo K, Yajima T, Kuwata T.
Characteristic transfer of colostrums-derived biologically active substances into
cerebrospinal fluid via blood in natural suckling neonatal pigs. J Vet Med A
Physiol Pathol Clin Med. 2002; Sep; 49(7): 358-364
46. Jeffcott LB. Studies on passive immunity in the foal. 11. The absorption of 125I-
labelled PVP (polyvinyl pyrrolidone) by the neonatal intestine. J Comp Path;
1974; 84: 279-289.
47. Jeffcott LB. The transfer of passive immunity to the foal and its relation to
immune status after birth. J Reprod. Fert., Suppl.; 1975; 23: 727-733
48. de Villiers WJ, Louw JP, Strachan AF, Etsebeth SM, Shephard EG, de Beer FC.
C-reactive protein and serum amyloid A protein in pregnancy and labor. Br J
Obstet Gynaecol. 1990 Aug; 97(8):725-30
49. Alsemgeest SP, Taverne MA, Boosman R, van der Weyden BC, Gruys E.
Peripartum acute-phase protein serum amyloid-A concentration in plasma of cows
and fetuses. Am J Vet Res. 1993 Jan; 54(1):164-7 
50. Jacobsen S, Niewold TA, Kornalijnslijper E, Toussaint MJ, Gruys E. Kinetics of
local and systemic isoforms of serum amyloid A in bovine mastitic milk. Vet
Immunol Immunopathol. 2005 Mar 10; 104(1-2):21-31
51. Blum JW, Baumrucker CR. Colostral and milk insulin-like growth factors and
related substances: mammary gland and neonatal (intestinal and systemic) targets.
Domest Anim Endocrinol. 2002 Jul; 23(1-2):101-10
52. Xanthou M, Bines J, Walker WA. Human milk and intestinal host defense in
newborns: an update. Adv Pediatr. 1995; 42:171-208
23
53. Walker WA. The dynamic effects of breastfeeding on intestinal development and
host defense. Adv Exp Med Biol. 2004; 554:155-70.
54. Oddy WH. The impact of breast milk on infant and child health. Breastfeed Rev.
2002 Nov; 10(3):5-18.
55. Kelleher SL, Lonnerdal B. Immunological activities associated with milk. Adv
Nutr Res. 2001; 10:39-65
56. Grosvenor CE, Picciano MF, Baumrucker CR. Hormones and growth factors in
milk. Endocr Rev. 1993 Dec; 14(6):710-28. Review
57. Slebodzinsky AB et al Triiodothyronine (T3), insulin and characteristics of 5'-
monodeiodinase (5'-MD) in mare's milk from parturition to 21 days post-partum.
Reprod Nutr Dev. 1998 May-Jun; 38(3):235-44.
58. Hess-Dudan F, Vacher PY, Bruckmaier RM, Weishaupt MA, Burger D, Blum
JW. Immunoreactive insulin-like growth factor I and insulin in blood plasma and
milk of mares and in blood plasma of foals. Equine Vet J. 1994 Mar; 26(2):134-9 
59. Murray MJ, Schaudies RP, Cavey DM. Epidermal growth factor-like activity in
mares' milk. Am J Vet Res. 1992 Oct; 53(10):1729-31
60. Schweigert FJ, Gottwald C. Effect of parturition on levels of vitamins A and E
and of beta-carotene in plasma and milk of mares. Equine Vet J. 1999 Jul;
31(4):319-23.
61. Mack DR, McDonald TL, Larson MA, Wei S, Weber A. The conserved TFLK
motif of mammary-associated serum amyloid A3 is responsible for up-regulation
of intestinal MUC3 mucin expression in vitro. Pediatr Res. 2003 Jan; 53(1):137-
42
24
62. Larson MA, Wei SH, Weber A, Mack DR, McDonald TL. Human serum amyloid
A3 peptide enhances intestinal MUC3 expression and inhibits EPEC adherence.
Biochemical and biophysical research communications; 2003; 300(2): 531-540
63. East LM, Dargatz DA, Traub-Dargatz JL, Dickinson CE, Ellis RP. Enterocolitis
associated with Clostridium perfringens infection in neonatal foals: 54 cases
(1988-1997). J Am Vet Med Assoc. 1998 Jun 1; 212(11):1751-6 
64. East LM, Dargatz DA, Traub-Dargatz JL, Savage CJ. Foaling-management
practices associated with the occurrence of enterocolitis attributed to Clostridium
perfringens infection in the equine neonate. Prev Vet Med. 2000 Jul 3; 46(1):61-
74
65. Sims LD, Tzipori S, Hazard GH, Carroll CL. Haemorrhagic necrotizing enteritis
in foals associated with Clostridium perfringens. Aust Vet J. 1985 Jun; 62(6):194-
6
66. Jones RL, Adney WS, Alexander AF, Shideler RK, Traub-Dargatz JL.
Hemorrhagic necrotizing enterocolitis associated with Clostridium difficile
infection in four foals. J Am Vet Med Assoc. 1988 Jul 1; 193(1):76-9 
67. Neu J. Weiss WD. Necrotizing enterocolitis: pathophysiology and prevention.
JPEN J Parenter Enteral Nutr. 1999 Sep-Oct; 23(5 Suppl):S13-7. Review.
68. Horton KK. Pathophysiology and current management of necrotizing
enterocolitis. Neonatal Netw. 2005 Jan-Feb; 24(1):37-46. Review
69. Oddy WH. The impact of breast milk on infant and child health. Breastfeed Rev.
2002 Nov; 10(3):5-18. Review.
25
70. Jeffcott LB, Rossdale PD. A critical review of current methods for induction of
parturition in the mare. Eq Vet J 1977; 9:208-15
71. Townsend HG, Tabel H, Bristol FM. Induction of parturition in mares: effect on
passive transfer of immunity to foals. J Am Vet Med Assoc 1983; 182:255-7 
72. Purvis AD. The induction of labor in mares as a routine breeding farm procedure.
Proc, Am Assoc Eq Pract 1977: 145-160
73. Ley WB, Parker NA, Bowen JM, DiGrassie WA, Jack NE. How we induce the
normal mare to foal. Proc, Am Assoc Eq Pract 1998; 44:194-197
74. Pashen RL. Low doses of oxytocin can induce foaling at term. Eq Vet J 1980;
12:85-7 
75. Leadon DP, Jeffcott LB, Rossdale PD. Mammary secretions in normal
spontaneous and induced premature parturition in the mare. Eq Vet J 1984;
16:256-9 
76. Macpherson ML, Chaffin MK, Carroll GL, Jorgensen J, Arrott C, Varner DD,
Blanchard TL. Three methods of oxytocin-induced parturition and their effects
on foals. J Am Vet Med Assoc 1997; 210:799-803
77. Hillman RB, Ganjam VK. Hormonal changes in the mare and foal associated with
oxytocin induction of parturition. J Reprod Fertil Suppl 1979; 27:541-6 
78. Rose RJ, Rossdale PD, Leadon DP. Blood gas and acid-base status in
spontaneously delivered, term-induced and induced premature foals. J Reprod
Fertil Suppl 1982; 32:521-8 
 
26
CHAPTER III
SPECIFICITY OF SERUM AMYLOID A CONCENTRATION AS AN INDICATOR
OF SEPSIS IN FOALS
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Abstract
It is questionable whether serum AA concentration is truly a specific indicator of equine
neonatal sepsis, therefore needing further investigation. Serum AA concentration was
measured in a population of 19 neonatal foals every 12 hours from birth until 72 hours
post partum. Blood samples and intensive clinical monitoring in the post partum period
were used to divide the foals into those with evidence of neonatal infection, those with no
evidence of infection but evidence of severe inflammatory disease and those that were
normal. The serum AA concentrations were evaluated to assess the specificity of this
measurement in the differential diagnosis of neonatal sepsis in the foal. Specificity at a
threshold concentration of 200mcg/ml was found to be 60 per cent, positive predictive
value (PPV) only 57 per cent and negative predictive value (NPV) was 82 per cent.
When the threshold concentration was increased to 500mcg/ml, the specificity increased
to 80 per cent, the PPV increased to 75 per cent and the NPV increased to 86%.
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Introduction
Neonates of all species are at an increased risk of developing infection. This is
particularly true for neonates born to high-risk dams. Conditions that place mares in a
high-risk category include: fescue toxicosis, equine Herpes virus 1 infection, twin
pregnancy, colic and endotoxemia, hydrops, abdominal hemorrhage, Caesarian-section,
malnutrition, systemic illness, trauma, chronic illness or administration of medications,
placentitis and induction of parturition (1). Other conditions that can indicate compromise
of the neonatal foal include dystocia, premature placental separation (red-bag birth),
prematurity/prolonged gestation and fetal diarrhea. Failure of passive transfer of
antibodies leads to increased risk of bacterial infection in the foal, as maternal
immunoglobulins do not cross the placenta (2).
Bacterial sepsis is probably one of the most common diagnostic challenges in neonatal
medicine (1). Early identification is vital so that appropriate treatment can be initiated,
but there is no single test that confirms sepsis early in the postpartum period. The
diagnosis of sepsis is generally made on clinical signs and suggestive hematology.
However, clinical signs of bacterial sepsis in neonates are variable and non-specific with
much overlap in signs between septic neonates and neonates with other conditions (1),
making identification of septic neonates difficult. The reporting of results of blood
culture can take days and frequent false negative and false positive results are obtained
(3).
Previous studies have examined various markers of sepsis and have developed a sepsis
score to predict sepsis in foals (4). This sepsis score, using a prevalence of about 50%,
had a sensitivity of 93 per cent, a specificity of 86 per cent, positive predictive value of
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89 per cent and negative predictive value of 92 per cent for the diagnosis of sepsis in
compromised neonatal foals. Numerous parameters were involved in determining the
score including the history and the clinical and laboratory findings. The sepsis score has
greater sensitivity and specificity for infection, with fewer false positive and false
negative values, than any of the parameters taken individually (4). However, a recent
evaluation of the sepsis score found it to have a sensitivity of only 67% and a negative
predictive value of only 55% (5). In this study, abnormal neutrophil cytology had a strong
association with sepsis. This is supported by another study describing the clinico-
pathologic features of sepsis in foals, where the most useful white blood cell parameters
were neutropenia, band neutrophils (greater than 0.2 X 10(9)/liter) and toxic changes in
the neutrophil population (6). Neutrophil counts of < 2000 cells per ml suggest early
overwhelming infection.
Sepsis occurs most commonly in the foal in the first 48 hours of life and the modes of
infection are intrauterine, oral, respiratory and via navel cord or traumatic penetration of
the skin (1). Microorganisms establish infection in the entry organ. The bacteria and their
toxins subsequently invade the blood stream causing damage to endothelium and the
release of cytokines that initiate the systemic inflammatory response and the increased
production of acute phase proteins (APPs). In human infants, the APP C-reactive protein
(CRP) is used to support a diagnosis of sepsis (7-9). In one study, the sensitivity,
specificity, positive predictive value (PPV), and negative predictive value (NPV) of CRP
for proven sepsis and localized infection at a cutoff point > or = 500 mcg/dl were 100 per
cent, 94 per cent, 91.6 per cent and 100 per cent respectively (7).
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Serum AA is an APP which is present in measurable quantities in normal equine neonatal
serum (10). The primary source of serum AA in the circulating plasma pool is
endogenous production from hepatic cells in response to inflammatory stimuli,
particularly IL6 (11). Recent work has supported the use of serum AA concentrations in
the differential diagnosis of sepsis in neonatal foals as its concentration appears to
increase dramatically in response to bacterial infection (12). In that study, foal serum AA
concentrations greater than 200 mcg/ml were strongly correlated with sepsis whereas
lower values (20-200mcg/ml) were suggestive of a non-infective acute phase response to
trauma or pre-maturity (12).
However, the acute phase response is by definition non-specific in that non-infectious
processes which cause tissue damage can elicit a similar acute phase response. Several
non-infectious disease processes lead to pathological changes in foals and present with a
clinical picture similar to that of sepsis. These include hypoxic-ischemic disease and
neonatal isoerythrolysis where hypoxic tissue damage can be considerable. Clinically, it
is frequently difficult to differentiate these conditions. In addition, it is likely that
extraneous sources of AA such as colostral AA protein could affect the serum
concentration of AA in the neonatal foal. Colostral macromolecules of molecular weight
19,000 – 58,000 can be absorbed in neonatal calves and piglets (13, 14). Serum AA has a
molecular weight of 11,400 – 12,500 in different species (15). Milk amyloid A, an
isoform of AA demonstrated in the colostrum of cows, sheep, humans and one mare has a
molecular weight of 12,800 (16).
Our hypothesis was that the measurement of serum AA using a threshold concentration
of 200mcg/ml is not a specific test for the differential diagnosis of sepsis in the neonatal
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foal. It is likely that other extraneous sources affect serum AA concentrations, and that
some non-infectious inflammatory conditions of neonatal foals are severe enough to elicit
an acute phase response similar to that seen with sepsis which would render the use of
serum AA concentration a less specific test for the differential diagnosis of sepsis.
Increasing the threshold concentration to 500mcg/ml may increase the specificity of the
test. The purpose of this study was to examine the dynamics of the AA protein in
neonatal foals with infectious and non-infectious inflammatory disease to evaluate the
sensitivity, specificity, positive predictive value and negative predictive value of the
measurement of this protein in the differential diagnosis of sepsis in neonatal foals.
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Materials and Methods
Animals
The study was conducted between January and July 2003. Nineteen pregnant mares in
residence at the Oklahoma State University College of Veterinary Medicine (OSU CVM)
Ranch were used. The 19 neonatal foals of the mares were intensively monitored during
the post-partum period. Sixteen mares were Thoroughbreds and 3 were Quarter Horses
(age range, 4 to 23 yr).
The low-dose oxytocin protocol (17) was used to induce parturition in the mares.
Calcium concentration in the mammary secretions was used to predict proximity to
parturition. Sampling was initiated 1 wk prior to expected foaling date or if the mare
displayed udder development. Samples were taken daily at 0800 until the calcium
concentration began to rise and then twice daily at 0800 and 1800. When the calcium
concentration was >200 ppm in two samples 24 h apart, parturition was deemed
imminent and the mare could be safely induced.
Before induction, the mares’ tails were wrapped, their perineum was washed with soap
and water, and they were placed in stalls bedded with clean straw. Parturition was
induced with 2.5 i.u. oxytocin (VEDCO, St Joseph, MO, USA) per dose given IV at 20-
min intervals until second stage labor was observed.
Physical examination of the mare and foal was done immediately following parturition
and peri-partum complications were recorded. At 12, 24, 48, and 72 h postpartum,
physical examination of the 19 foals was performed. Sequential complete blood counts
in the foals at 24, 48 and 72 h were utilized to assess health status. Serum IgG
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concentrations in foals at 24 h of age were measured using a commercially available
ELISA (SNAP Foal IgG Test, IDEXX Laboratories, Inc. Westbrook, MN, USA).
Because there is no definitive pre-mortem test for sepsis in foals, foals were
retrospectively allocated to 3 different groups; Group 1: completely normal; Group 2:
evidence of inflammatory disease but no suspicion of sepsis; and Group 3 strong
suspicion of sepsis. A normal foal was defined as one with a normal gestational length
and a normal placenta (i.e. no gross pathological changes), stood within 2 hours and
nursed within 3 hours of parturition, had a serum IgG concentration measurement > 4 g/l
at 24 hours, a neutrophil count within the normal range (4000 and 8,000/ml) at 24, 48 and
72 hours and presented with no clinical signs of disease within the first 3 days.
Conditions which would have excluded foals from the normal group included a maternal
history of fescue toxicosis, equine herpesvirus 1 infection, twin pregnancy, colic and
endotoxemia, hydrops, abdominal hemorrhage, Caesarian-section, malnutrition, systemic
illness, trauma, chronic illness or administration of medications or placentitis, or
premature separation of the placenta, prematurity/prolonged gestation, fetal diarrhea,
dystocia, failure of passive transfer of antibodies or abnormal neutrophil counts.
Parameters which assigned foals to the septic group included neutropenia with or without
band neutrophils and toxic changes and clinical evidence of infection such as fever,
depression, petecchial hemorrhages, localized heat, pain and swelling, or other evidence
of systemic infection.
34
Samples for serum AA analysis
Blood samples were collected into evacuated plain glass tubes from each neonatal foal
prior to colostrum ingestion and at 12, 24, 36, 48, 60, and 72 h postpartum. The foals
were gently and carefully restrained to prevent traumatic venipuncture and generation of
an inflammatory response associated with the venipuncture site. Where possible,
umbilical cord blood was substituted for the pre-colostral sample to prevent unnecessary
stress associated with venipuncture of the newborn foal. Blood samples were stored at 4
0C until a clot had formed; they were subsequently centrifuged at 699 x g for 5 min and
the serum was separated and frozen at –20 oC for later analysis.
Serum AA concentrations
All samples were analyzed for serum AA concentration using Tridelta´s Phase™ Range
SAA assay (Tridelta Limited, Maynooth, Co Kildare, Ireland). This assay was previously
described in studies that measured serum AA concentrations in clinically normal and
diseased horses [16, 18]. Data are expressed as mcg/ml. On the first plate, samples were
measured in duplicate and thereafter once only. The minimum detectable concentration of
serum AA was 5 ng/ml. The intra-assay coefficient of variation was 7.7 and 5.3% at
mean serum AA concentrations of 74 and 128 µg/ml respectively. The inter-assay
coefficient of variation was 10.8 and 8.7% at mean serum AA concentrations of 81 and
134 µg/ml respectively.
Statistical analysis of data
The natural log of serum AA, was modeled using a mixed model, fitted using the Mixed
procedure in SAS® v 9.1 (SAS Institute Inc., 2003). A backward selection procedure
was used to determine an appropriate model; factors remaining significant (P < 0.05)
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were retained in the model. The repeated measurements within a foal at different times
were examined by including foal as a random effect. The significance of the random
effect was tested by comparing a model excluding the random effect using a likelihood
ratio test. Disease, time and the two-way interaction between these variables were fitted
as fixed effects. Time was checked for linearity by the inclusion of quadratic terms and
by comparing models that included log of time, with time as a categorical variable and
time as a continuous variable. This analysis was then repeated including only the results
from the abnormal foals. Suspicion of sepsis, time and the two way interaction between
these variables were fitted as fixed effects.
To differentiate between abnormal foals which were considered septic and abnormal
foals suffering from another inflammatory disorder, sensitivity (the probability of the test
being positive when disease is present), specificity (the probability of the test being
negative when disease is absent), positive predictive value (PPV) (the probability of
having the disease if the test was positive) and the negative predictive value (NPV) (the
probability of not having the disease if the test was negative) were calculated for the use
of serum AA concentration in neonatal foal serum over the first 72 hours of life.
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Results
Subjects
Nineteen mare-and-foal pairs were included in the study. One mare was foaled by
elective Caesarian section. Parturition was induced in 11 mares. Seven mares foaled
spontaneously before the 24-h sample was taken. One mare foaled prematurely (317 d)
but the foal was healthy, and no complications developed. Regarding normalcy and
partition induction, of the 11 mares with induced parturition, 7 had normal foals and 4
had abnormal foals.
Allocation to Groups
All foals had serum IgG concentrations > 4g/L at 24 h. Nine of the 19 foals were
designated normal (according to our definition) and allocated to the normal group, Group
1. Ten foals were excluded from the normal group and were allocated further based on
suspicion of sepsis.
Of the 10 abnormal foals, 5 foals were without signs suggestive of sepsis and were
allocated to Group 2. Of these five foals, one was premature but was otherwise normal
and did not require treatment. One had an abnormal neutrophil count (3000-4000
cells/ml) but was not treated and developed no further complications. Another foal took
longer than 3 hours to nurse; however, it did not develop any further complications and
the IgG concentration was >8g/l at 24 hours. One foal was delivered following dystocia
but did not develop any clinical or laboratory findings suggestive of disease or
subsequent complications. Finally, one foal suffered from progressive bilateral hind-limb
paresis that became apparent 3 days after Caesarian section delivery. This foal was
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eventually euthanized and diagnosed on post mortem with ischemia in the lumbo-sacral
spinal cord.
Of the ten abnormal foals, five were considered to have a high index of suspicion of
sepsis and were included in Group 3. These five foals developed neutrophil counts <2000
and were treated with ceftiofur sodium (5 - 10 mg/kg BID IV) for 3-5 days. Three of
these foals did not develop clinical signs consistent with sepsis and did not require further
intervention. One more foal was slow to nurse having suffered premature placental
separation at birth. None of these four foals developed subsequent complications. The
fifth foal developed clinical signs consistent with sepsis including fever, severe
depression and mucosal petecchiation. Placentitis was detected in the dam’s placenta at
birth. The foal was intensively treated with broad-spectrum antibiotics (potassium
penicillin and amikacin), hyper-immunized plasma and anti-inflammatory drugs
(ketoprofen) and survived.
Normal and abnormal foals and their serum AA concentrations
At birth, the 9 normal foals had serum AA concentrations in the previously described
range (i.e. < 20 mcg/ml). Their serum AA concentration ranged from 0.6 to11 mcg/ml
(mean 6 +/- 3.2) (Table 1). Over the first 72 hours, however, the serum AA
concentrations of these normal foals varied over a wide range (e.g. at 48 hours they
ranged from 4 to 197mcg/ml (mean 43.2 +/- 62)), but these concentrations remained
below the previously described septic range (> 200mcg/ml) although 6 of them were in
the range indicative of inflammatory disease (i.e. >20mcg/ml).
Within the group of 10 abnormal foals a wide range of conditions and serum AA
concentrations were observed (Tables 2, 3). Although the five foals in Group 2 did not
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have clinical or laboratory findings suggestive of sepsis, 2 of them developed serum AA
concentrations in the range previously described as indicative of sepsis (i.e.> 200mcg/ml)
(Table 2). One of these was approximately 5 hours old before it nursed. It was otherwise
clinically normal and had a normal IgG at 24 hours. Serum AA concentration peaked at
407mcg/ml at 36 hours, well within the described range for septic foals. Colostral
concentration of AA in this foal’s dam was 967 mcg/ml. The other foal developed
bilateral hind-limb paralysis after Caesarian section delivery and was diagnosed on post
mortem with ischemia in the lumbo-sacral spinal cord, but there was no post mortem
evidence of sepsis. That foal did not develop an abnormal neutrophil count and besides
initial depression, attributed to hypoxia after C-section delivery, no other clinical findings
suggestive of sepsis were observed at any time. However, its serum AA concentration
peaked at 560 mcg/ml at 36 hours.
Of the 5 foals that did develop clinical or laboratory findings suggestive of sepsis (Group
3), four foals had serum AA concentrations that peaked in the exceedingly high range of
(500 – 1050 mcg/ml) (Table 3). However, one had a serum AA concentration that
peaked at 191mcg/ml, slightly below the range previously described for sepsis. The peak
concentration of serum AA concentrations in these foals occurred at different times
consistent with the non-specific acute phase response. In one foal, the peak occurred at
24 hours and lasted to 60 hours at which time it began to decrease. In the other foals, the
peak occurred at 48 to 60 hours and then began to decrease. In most cases, the decreased
neutrophil count preceded the rise in serum AA concentration.
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Statistical analysis
In the analysis of all of the foals, the random effect of foal was not significant (p = 1.00).
The fixed effects, (disease and time), were both significant (p<0.001), and the 2-way
interaction was significant (p < 0.01) (Fig. 1). Time, fitted as a categorical variable, gave
a better fitting model compared to when fitted as a continuous, quadratic or logistic
variable. The least-square mean serum AA for abnormal foals was significantly larger
(p< 0.05) than for normal foals with means of 66.3 and 13.3 respectively. The least-
square mean serum AA for normal foals was significantly lower (p< 0.05) than for
abnormal foals after 12 hours (see Table 4).
In the analysis of the 10 abnormal foals, the random effect of foal was not significant (p =
0.206). The fixed effects, suspicion of sepsis status and time, were both significant
(p<0.001), however, the 2-way interaction was not significant (p = 0.457). The least-
square mean serum AA for septic foals was significantly larger (p< 0.05) than for non-
septic foals with means of 123.3 and 35.0, respectively.
Taking the 10 abnormal foals into account when comparing Groups 2 and 3, and using
the serum AA threshold concentration of > 200mcg/ml for the differential diagnosis of
sepsis in compromised foals, the sensitivity of the serum AA results was 80 per cent and
the specificity was 60 per cent.
Previous studies which evaluated prognostic and diagnostic variables in neonatal foals
used a prevalence of 30-50 % for sepsis in abnormal (hospitalized) foals (19-20). Using a
prevalence of neonatal sepsis of 40 %, the PPV and NPV of using serum AA
concentration greater than 200 mcg/ml for the differential diagnosis of sepsis in neonatal
foals were 57 % and 82 % respectively. If the serum AA concentration threshold for the
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diagnosis of sepsis were increased to 500 mcg/ml, the sensitivity and specificity would
both be 80 %, additionally the PPV and NPV would be 73% and 86% respectively.
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Discussion
Of the 19 foals included in this study, only 9 were considered completely normal by the
definition described in the methods section. One might question the extremely high
number of complications in this study. The definition of normality that was used,
however, was strict; foals that were considered abnormal in this study might have gone
undetected in an environment where complete blood counts are not performed routinely
every day, and foals are not intensively monitored.
Of the 10 abnormal foals, 5 had < 2000 cells per ml at some point over the 72 hours.
These were considered to have clinical or laboratory findings suggestive of sepsis in
accordance with a study describing the clinico-pathologic features of sepsis in foals,
where the most useful white blood cell parameters were neutropenia, the presence of
band neutrophils (greater than 0.2 X 109/liter) and toxic changes in the neutrophil
population (6). However, only one foal showed clinical signs which were suggestive of
sepsis i.e. fever, depression and petecchial hemorrhages.
As in the human infant, there is no definitive pre-mortem test for sepsis in the neonatal
foal. In human infants, acute phase protein measurements are used to indicate sepsis (21-
25). Recently serum AA was proposed as an aid in the diagnosis of sepsis in neonatal
foals (12). In our study, there was a significant difference in the serum AA concentration
between the normal foals (Group 1) and the abnormal foals (Groups 2 and 3) after 12
hours similar to that previously described (10). Serum AA concentrations clearly
differentiate between groups of normal and compromised foals in the neonatal period. In
addition, there was a significant difference in serum AA concentrations between
compromised foals with a high index of suspicion of sepsis and those in which a non-
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infectious problem was present. The change in serum AA concentration over time
between these groups, however, did not differ.
It is suggested that serum concentrations of AA greater than 200mcg/ml are consistent
with a diagnosis of sepsis in the compromised neonatal foal, and that concentrations of
20-200mcg/ml are consistent with non-septic inflammation. Without a way to definitively
diagnosis sepsis in foals it is difficult to comment on the sensitivity of this test. However,
we can make an observation on the specificity of the test for the foals in this study. Two
of five abnormal foals with no clinical or laboratory evidence of sepsis had serum AA
concentrations in the range associated with sepsis when a serum AA threshold of
200mcg/ml was used. In human infants, it is believed that in cases of perinatal asphyxia
and infection equivalent increases in serum levels of inflammatory mediators are found
(26). Similarly we found an extremely high serum AA concentration in the foal with
spinal ischemic necrosis and no clinical, laboratory or post-mortem evidence of sepsis.
This foal was delivered by Caesarian section and most likely suffered ischemia during the
delivery. However, this finding lends further support to the argument that serum AA is
not a specific indicator of sepsis. A second foal had a serum AA concentration in the
septic range but did not have any clinical or laboratory evidence suggestive of sepsis,
however, the concentration of AA in the colostrum of this foal’s dam was exceedingly
high (data not shown, see chapter IV). Therefore, colostral AA may be absorbed in the
early post partum period of increased macromolecular absorption in the neonatal foal. We
have shown a significant correlation exists between peripartum colostrum AA
concentration in the dam and post-partum serum AA concentrations in their foal
approximately 48 h after birth (27). Alternately, the mild post-partum colic in this mare
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may have been caused by a peri-partum event that may also have lead to a post partum
increase in serum AA concentration in the neonatal foal.
The specificity of serum AA concentrations for the differential diagnosis of sepsis using a
threshold concentration of 200 mcg/ml was 60%, the PPV (i.e. the probability of having
the disease if the test was positive) at a prevalence of 40% was only 57 per cent and the
NPV (i.e. the probability of being disease free if the test is negative) was 82 per cent.
When the threshold concentration was raised to 500 mcg/ml, the specificity of the test
increased to 80 per cent, PPV increased from 60 per cent to 73 per cent and NPV
increased to 86 per cent. While the usefulness of using serum AA in the differential
diagnosis of sepsis in compromised foals increases by raising the threshold of the test, it
still does not approach the usefulness of the acute phase protein CRP in the diagnosis of
neonatal sepsis in human infants (sensitivity 100 per cent, specificity 94 per cent, PPV
91.6 per cent and NPV 100 per cent) or using the sepsis score in foals (sensitivity 93 per
cent, specificity 86 per cent, PPV 89 per cent and NPV 92 per cent).
We suggest that as an indicator of sepsis in compromised neonatal foals, the threshold
concentration of serum AA indicative of sepsis should be raised to 500mcg/ml and it
should be interpreted carefully in the light of clinical and laboratory findings. In addition,
investigation of the measurement of CRP as an indicator of sepsis in compromised foals
should proceed.
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Table 1. Group 1 foal serum AA concentrations (mcg/ml)
Mare Comments Foal serum
0 hr 12 hr 24 hr 36 hr 48 hr 60 hr 72 hr
17 Normal 7.6 8.1 43.5 23.4 24.4 14.5 12.1
25 Normal 7.8 9.5 12.8 12.7 13.7 9.0 10.6
27 Normal 6.3 13.2 19.2 20.4 22.2 13.5 12.1
28 Normal 11.0 16.8 20.7 21.8 18.3 15.4 16.8
29 Normal 4.5 55.4 94.0 96.0 81.6 30.5
30 Normal 8.7 6.6 12.4 11.0 15.0 15.1
31 Normal 4.3 15.1 20.3 61.7 197.4 53.5 29.1
32 Normal 0.6 6.7 19.5 17.1 13.1 11.7 9.2
33 Normal 2.8 34.6 5.5 10.9 3.8 0.1 4.3
Mean 6.0 18.4 27.5 30.5 43.3 16.6 15.6
SD 3.2 16.3 27.0 29.0 62.0 15.7 9.5
Table 2. Group 2 foal serum AA concentrations (mcg/ml)
Mare Comments Foal serum
0 hr 12 hr 24 hr 36 hr 48 hr 60 hr 72 hr
12 C-section, hypoxia, ischemia 5.1 58.0 45.3 557.9 418.2 82.8 102.5
19 Mildly decreased neutrophils 7.8 24.4 74.7 60.3 52.3 31.7
36 Premature 0.6 12.6 43.4 39.5 28.2 11.4 32.8
37 Maternal colic, slow to nurse 2.3 323.8 262.4 406.8 373.0 259.7 239.8
38 Mild dystocia 7.0 5.0 4.5 6.0 5.7 54.5 5.0
Mean 4.6 84.8 86.1 252.5 177.1 92.1 82.3
SD 3.1 135.1 101.7 272.8 201.0 97.1 95.1
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Table 3. Group 3 foal serum AA concentrations (mcg/ml)
Mare Comments Foal serum
0 hr 12 hr 24 hr 36 hr 48 hr 60 hr 72 hr
15 Placental separation, slow to nurse,
neutrophil < 2000 cells/ml
3.9 22.5 133.8 185.3 191.1 129.3 68.1
16 Neutrophils < 2000 cells/ml 10.9 10.3 14.3 48.4 412.3 1042.0 851.1
17 Neutrophils < 2000 cells/ml 3.7 69.8 315.2 432.2 510.3 415.2 221.9
24 Mild dystocia; neutrophils < 2000 cells/ml 6.0 28.9 215.5 363.2 457.5 622.2 395.0
34 Placentitis, clinical sepsis, neutrophils <
2000 cells/ml
2.1 124.5 744.6 744.6 744.6 744.6 723.4
Mean 5.3 51.2 284.7 354.7 463.1 590.7 451.9
SD 3.4 46.7 279.8 264.9 198.8 343.5 330.4
Table 4. Least square means and 95% confidence intervals
Time Normal Abnormal
LSM Lower Upper LSM Lower Upper P-value
0 4.7 2.0 10.8 3.9 1.7 8.5 0.737
12 14.1 6.1 32.6 33.3 15.1 73.8 0.142
24 20.2 8.7 46.7 83.7 37.8 185.2 0.016
36 22.7 9.8 52.5 156.5 67.7 361.5 0.002
48 22.7 9.8 52.6 170.6 77.1 377.5 0.001
60 8.2 3.4 20.0 168.2 76.0 372.3 <0.001
72 13.2 5.4 32.0 116.7 52.7 258.4 <0.001
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Figure 1: Mean serum AA concentrations over time for normal and abnormal
foals
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Figure 2: Mean serum AA concentrations over time for abnormal foals
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CHAPTER IV
AMYLOID A IN EQUINE COLOSTRUM AND EARLY MILK
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Abstract
The objective of this study was to investigate the presence of amyloid A in equine
colostrum and milk. Thirty-eight peripartum mares were included in the study.
Amyloid A (AA) concentrations were measured in peripartum maternal serum and
colostrum and in early milk samples and found in all samples. Mean maternal serum
concentrations of AA at parturition were consistent with previous studies, although
the variation was wide. Colostrum and milk AA concentrations were consistently
higher than peripartum maternal serum AA concentration. There was no correlation
between serum and colostrum AA concentrations at parturition. There was no
significant association found between the factors examined: age, breed, farm of
residence, length of gestation, clinical abnormality or induction of parturition and the
mare serum AA concentration at parturition. There was no effect of age, breed, farm
of residence, or clinical abnormality on the concentration of AA in the colostrum or
milk. For every 1 day increase in gestation there was an incremental fall in AA
concentration in colostrum and milk. Mares that were induced to foal had a
significantly lower AA concentration in colostrum and milk compared with mares
that were not induced.
We conclude that AA is consistently present in equine colostrum and early milk at
higher concentrations than in the maternal serum at parturition. Milk AA has been
shown to protect the human infant intestine against infectious disease. Further studies
are necessary to investigate the dynamics and the function of this colostral and milk
protein and to assess whether equine colostral and milk AA has a protective function
in the equine neonatal intestine.
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Introduction
Serum amyloid A (AA) is an acute-phase protein that increases in response to
inflammatory stimuli in horses (1). Serum AA concentration in normal pregnant and
non-pregnant mares has been previously published (1); 6-7 year old mares had
average serum AA concentrations of 21.24 mcg/ml; 8-10 year old mares had average
concentrations of 28.49 mcg/ml; 11-15 year old mares had average concentrations of
21.04 mcg/ml; 16-20 year old mares had concentrations of 26.58 mcg/ml and mares
older than 21 years had average concentrations of 30.33 mcg/ml . In the same study,
pregnant mares 2 days pre-partum had serum concentrations of 23.81 mcg/ml and one
day post-partum had serum AA concentrations of 51.83mcg/ml. Three days post-
partum mean serum AA concentrations had increased to 136.78 mcg/ml indicating
that parturition is an inflammatory event for the brood mare.
Acute phase proteins have been detected in the colostrum and milk of many species
(2-4). An isoform of AA was recently demonstrated in the colostrum and early milk
of women, cows, ewes, sows and one mare (3). This colostral and milk isoform of AA
is called milk amyloid A and is synthesized extra-hepatically in mammary gland
cells. It is produced by healthy animals, expressed by bovine mammary gland
epithelial cells and secreted in abundance as part of a normal process in response to
prolactin (5). In cows, the concentration of this protein is particularly high in
colostrum but declines rapidly to reach low concentrations by 3 days post-partum (3).
Besides being synthesized and secreted in normal colostrums Lipopolysaccharide and
Staphylococcus aureus lipotechoic acid stimulate synthesis of milk AA (5, 6), and
cows with mastitis have very high concentrations of AA in the milk. The function of
this protein in relation to the diseased tissue has not been elucidated; however, the
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protein is used as an early marker of mastitis in cows (6-10). Recently, serum AA
accumulation in mastitic milk was shown to result from both local synthesis of AA
(milk AA) and hepatic-derived AA (serum AA) that gains access to the milk due to
increased permeability of the blood-milk barrier (9). However, a pathogen must be
present in the mammary gland for AA from the serum to accumulate in milk (11).
Amyloid A was previously detected at a high concentration (704 mcg/ml) in the
colostrum of one normal mare (3). When AA was affinity purified from that sample
and sequenced, only one isoform (milk AA) was detected, and it was concluded that
equine colostrum contained only milk AA (A Weber, personal communication), at
least in normal lactating mammary glands. Clinical mastitis is uncommon in mares,
so it is not unusual that only the mammary-derived amyloid A is present in mares’
colostrum and milk. The concentration of milk AA in the mare was particularly high
(704 mcg/ml) in comparison with that in bovine colostrums (267 mcg/ml) (3) and in
previously reported equine serum at parturition (23.8 mcg/ml) (1). The concentration
of this protein in early milk in that mare was not determined. To date, no further work
has been done to elaborate the presence and concentration of this protein in equine
colostrum or milk.
Recent research has focused on the many beneficial factors in colostrum and milk of
a number of species, which promote both intestinal development and the development
of other neonatal tissues (12-18). In humans milk AA has been shown to have
protective effects in the infant intestine (19, 20). Given its protective effects it is
appropriate for this protein to be delivered in high concentrations to the developing
neonatal intestine. Milk AA functions in preventing the attachment of pathogenic
bacteria to the intestinal wall and in the up-regulation of local protective factors such
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as mucins (19, 20). Due to these protective effects, the milk AA protein has been
promoted as a deterrent in the development of necrotizing enterocolitis in human
infants (20). Necrotizing enterocolitis also frequently affects compromised neonatal
foals and has a high case mortality risk (21-24). Unfortunately, there has been limited
research in this field in the mare (25-28). It is important that the beneficial
components in mare colostrum and milk are identified as they have been in other
species.
The purpose of this study was to determine the concentration of milk AA in
colostrum and early milk in a large group of broodmares and examine the variables
that might affect those concentrations.
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Materials and Methods
Animals
The study was conducted between January 2003 and July 2004. Thirty-eight pregnant
mares, 30 in residence at the Oklahoma State University College of Veterinary
Medicine ranch and 8 pregnant mares in residence at the Oklahoma State University
Animal Science facility were used for this study. Eighteen mares were
Thoroughbreds, 1 was Hanoverian and 19 were Quarter Horses, with an age range of
4 to 23 years old. There was no evidence of clinical mastitis in any mare. Careful
records were kept in the peri-partum period with regard to clinical conditions,
induction of parturition and complications of parturition.
The low-dose oxytocin protocol (29) was used to induce parturition in the mares.
Calcium concentration in the mammary secretions was used to predict proximity to
parturition. Sampling was initiated 1 wk prior to expected foaling date or if the mare
displayed udder development. Samples were taken daily at 0800 until the calcium
concentration began to rise and then twice daily at 0800 and 1800. When the calcium
concentration was >200 ppm in two samples 24 h apart, parturition was deemed
imminent and the mare could be safely induced. All eight of the OSU Animal Science
Department mares were allowed to foal spontaneously. Before induction, the mare’s
tail was wrapped, her perineum was washed with soap and water, and she was placed
in a 15 x 25 ft. maternity stall bedded with clean straw. Parturition was induced with
2.5 i.u. oxytocin (VEDCO, St Joseph, MO, USA) per dose given IV at 20-min
intervals until second stage labor was observed. Physical examination of the mare
was done immediately following parturition and peri-partum complications were
recorded.
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Samples
Colostrum samples were collected in plain plastic tubes from each mare at
parturition. Milk samples were obtained in plain sterile plastic tubes at 12, 24 and 48
hours post partum from 30 mares. The colostrum and milk samples were promptly
refrigerated and then stored in a freezer at –20o C. Blood samples were collected in
plain glass tubes from each mare at parturition. Blood samples were immediately
refrigerated until a clot had formed; then they were centrifuged at 2500 rpm for 5
minutes, and the serum was separated and frozen at –20oC for later analysis.
Analysis of colostrum, milk and serum amyloid A
All samples were analyzed for serum AA concentration using Tridelta´s Phase™
Range SAA assay (Tridelta Limited, Maynooth, Co Kildare, Ireland). This ELISA as
has been previously described for colostrum and serum from several species
including the mare (3, 30). Data are expressed as mcg/ml. On the first plate, samples
were measured in duplicate and thereafter once only. The minimum detectable
concentration of serum AA under the assay was 5 ng/ml. The intra-assay coefficient
of variation was 7.7% and 5.3% at mean serum AA concentrations of 74 and 128
mcg/ml respectively. The inter-assay coefficient of variation was 10.8% and 8.7% at
mean serum AA concentrations of 81 and 134 mcg/ml respectively.
Statistical analysis
Data were analyzed to determine whether age, breed, farm of residence, gestation
length, clinical status or induction of parturition affected the concentrations of the
protein in the mares’ serum, colostrum or milk.
Correlation between mare serum and colostrum concentration at parturition was
assessed using Pearson correlation (Microsoft Excel). Statistical analyses of the
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association of the various factors with serum, colostrum and milk AA concentrations
were performed using SAS® v 9.1 (SAS Institute Inc., 2003).
For serum AA, the natural log of AA was modeled using a general linear model,
fitted using the GLM procedure in SAS. A forward selection procedure was used to
determine an appropriate model; factors remaining significant (P < 0.05) were
retained in the model. The variables tested as fixed effects were: age, breed, farm of
residence, gestation length, clinical examination (normal/abnormal) and induction of
parturition (Yes/No, note a c-section was classified as No).
For colostral and milk AA, the natural log of AA was modeled using a mixed model,
fitted using the Mixed procedure in SAS. A forward selection procedure was used to
determine an appropriate model; factors remaining significant (P < 0.05) were
retained in the model. The repeated measurements for a mare at different times were
dealt with by including mare as a random effect. The significance of the random
effect was tested by comparing a model excluding the random effect using a
likelihood ratio test.
The variables tested as fixed effects were: time, age, breed (Hanoverian/QH/TB),
farm of residence, gestation length, clinical examination (normal/abnormal) and
induction of parturition (Yes/No, note a Caesarian-section was classified as No).
Time was checked for linearity by the inclusion of quadratic terms, and comparing
models that included log of time, time as a categorical variable and time as a
continuous variable.
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Results
Thirty-eight mares were included in the study. Information on age, breed, farm of
residence, gestation length, induction of parturition and clinical findings are presented
in Table 1.
The mare serum, colostrum and milk AA concentrations are presented in Table 2.
The mean concentration of this protein in the colostrum was 154 +/- 174 mcg/ml; in
12 hour milk was 296 +/- 246 mcg/ml; in 24 hour milk was 315 +/- 229 mcg/ml and
in 48 hour milk was 332 +/- 252 mcg/ml. One mare delivered prematurely at 317
days (#36); the foal was clinically normal, but the mare’s serum AA concentration
was relatively high compared to previously published values (61 mcg/ml). One mare
suffered mild dystocia i.e. one leg folded back at the knee (#38); however this was
quickly corrected, and the foal delivered promptly. Serum AA was also relatively
high in this mare (58 mcg/ml). One mare had no abdominal contractions and was
assisted to foal (#24). Her serum AA remained low (20.5 mcg/ml). One mare
suffered placentitis (#34) and the foal was presumed septic but this mare’s serum AA
remained low (5.7 mcg/ml). One mare suffered mild post partum colic which
resolved without treatment (#37). This mare’s serum AA concentration was high (136
mcg/ml), and her colostrum AA concentration was also particularly high (967
mcg/ml). One mare suffered atrial fibrillation for 12 hours post partum which
converted spontaneously to a normal rhythm (#1). Her serum AA concentration was
similar to previously published normal values (32mcg/ml) (1).
Two mares retained the fetal membranes (#13 and # 20) and one mare had placenta
previ (red bag delivery) (#15); however, the serum and milk AA concentrations in
these mares were not particularly high (Table 2). One mare underwent elective
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Caesarean section due to an intra-pelvic mass (#12). Although pre- and post-surgical
serum AA concentrations in this mare differed greatly (from 4.3 to 291 mcg/ml),
there was no difference between the colostrum and milk concentrations of AA in this
mare from those in the rest of the group.
Statistical analysis – There was no correlation between mare serum AA
concentration at parturition and colostral AA concentration in this group of mares.
In the analysis of AA in the mare serum at parturition none of the examined variables
age, breed, farm of residence, gestation length, induction of parturition or clinical
examination were significant (p>0.05).
In the analysis of AA in colostrum and milk the random effect of mare was
significant (p < 0.05). The within mare variation was 23%. The variables time
(p<0.001), gestation length (p < 0.05) and induction of parturition (p < 0.05) were
significant. The other variables, breed, age, farm of residence and clinical
examination were not significant. The two-way interaction of time x induction was
not significant. Gestation length was included in the model as a continuous variable.
For every 1 day increase in gestation length there was a fall in log AA by a factor of
0.98. When AA was compared at each of the time categories, the mean AA at time 0
was significantly lower (p<0.001) than at all other times. The mean AA
concentrations at all other times were not significantly different.
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Discussion
The mean serum AA concentration in pregnant mares at parturition in this study (36
mcg/ml) is slightly higher than that presented in a previous study (23.8 mcg/ml) (1);
however, the variation in maternal serum concentration in this study was wide (Table
1). The population of horses described in the previous study included only
Thoroughbreds and Arabians. This study included 18 Thoroughbreds, 19 Quarter
Horses and one Hanoverian. When breed effects were examined, there was a
tendency (p=0.08) towards lower serum concentrations of this protein in
Thoroughbreds (average concentration 20.2 mcg/ml) than in Quarter Horses (average
concentration 52.5 mcg/ml) although breed difference was not significant (Table 3).
This may explain the lower concentration seen in the previous study which included
primarily Thoroughbreds. The concentration seen in the serum of the Hanoverian
mare (5.6 mcg/ml) was similar to that seen in many other mares.
There was no significant association found between the age of the mares and the
concentration of serum AA at the time of parturition. This infers that the production
of this protein is not related to the health or otherwise of the mammary gland and
suggests that it may have more to do with providing large quantities of this protein to
the neonate no matter the age of the mare. No association was found between the
farm of residence of the mares and their serum AA concentrations at parturition. This
is not unexpected, because management of the mares on the two farms and their
health statuses were not dissimilar. Although the only mare that foaled prematurely
did have a high serum AA concentration compared with the mean (69.1 mcg/ml vs 36
mcg/ml) an association between the length of gestation and the maternal serum AA
concentrations at parturition could not be inferred.
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There were a variety of clinical abnormalities detected in some of the mares. One
mare had placentitis, one had slight postpartum colic, two suffered mild dystocia and
one had transient atrial fibrillation for 12 hours post partum. One mare underwent
elective Caesarian section at full term and predictably its serum AA concentrations
increased markedly after surgery (from 4.3mcg/ml to 291mcg/ml in 12 hours). Two
mares retained the fetal membranes and one mare suffered placenta previ (red-bag
delivery). However, no association was found between clinical abnormality and
maternal serum AA concentration at parturition. Perhaps these conditions were
localized enough not to cause a systemic response; or if they were severe enough to
cause a systemic response, we were sampling at the beginning of the 16 hour lag
period after inflammatory stimulus before a rise in serum AA is detectable.
Sequential serum samples from the 72 hours after parturition would be needed to
draw any meaningful conclusions about the association between the health of the
mare at parturition and the concentration of serum AA in her serum. No association
was found between induction of parturition and serum AA in the mare at parturition.
This is not surprising as induction was performed at parturition, and the lag period
after an inflammatory stimulus before serum AA concentrations rise in the serum is
about 16 hours.
Recent work has detected a mammary-derived isoform of AA in a number of species
including one mare (3). The mare’s colostrum had an AA concentration of 704
mcg/ml. In this study we demonstrated the consistent presence of AA in the
colostrum and early milk of a large number of mares (Table 2). The concentration of
AA in colostrum and milk was found to be considerably higher than the concentration
in the serum of each mare at parturition. Therefore, the AA in the colostrum and milk
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samples in this study may be mammary derived and not derived from serum AA or a
combination. This is consistent with the previous study which, by affinity purification
and sequencing, revealed only one isoform (milk AA) in the sample of mare’s
colostrums that was examined (3). In bovine mastitic milk, both serum and milk
isoforms of AA are present in the milk (9). There was no evidence of mastitis in the
mares in this study. In addition, and as found in cattle, there was no correlation
detected between serum AA and colostral AA concentrations at parturition.
In healthy bovine milk, AA concentrations were minimal by day 2-3 post-partum (3);
equine milk AA concentrations, on the other hand, remained consistently high in this
study until at least 48 hrs post partum. In fact, the concentration of this protein in the
milk after 12 hours was significantly higher than that in colostrum. This suggests a
possible important role for this protein in the equine neonatal intestine similar to that
found in humans and cows (19, 20). A conserved four-amino-acid motif (TFLK)
contained within the first eight N-terminal amino acid residues of this protein is
thought to be responsible for its beneficial effects in the intestine (19). This protein
protects the infant intestine by enhancing the innate immunity of intestinal cells (19,
20). It up-regulates production of the intestinal mucin, MUC3, in infant intestinal
cells, which provides a protective barrier in the gut (19, 20). Human milk AA also has
a species-specific effect in decreasing the attachment of pathogenic organisms to
human neonatal intestinal cells (20). If, as in other species, the equine isoform of AA
has protective effects in the neonatal intestine, it may be appropriate to have a higher
concentration of this protein in the milk from which it will not be absorbed after gut
closure.
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Age, breed and farm of residence did not appear to influence the concentration of AA
in the colostrum or the early milk. Nor did clinical abnormalities present affect these
concentrations. Although prolactin, lipopolysaccharide and Staphylococcus aureus
lipotechoic acid are known to stimulate the production of this mammary-derived
protein in other species (5,6), it is not known what stimulates production of this
protein in the equine mammary gland. In any event none of the mares suffered
clinical endotoxemia nor did any mare display clinical evidence of mastitis; therefore,
the stimulus for milk AA production in this study was most likely physiologic.
Gestation length did appear to be associated with colostrum and milk AA
concentration. Three hundred and forty two days is the recognized normal gestation
length in mares; however, mares have been known to foal naturally from 320 to 380
days. For every one day increase in gestation length, the log of AA in the colostrum
and milk decreased by a factor of 0.98. This may be due to increased volume of
milk present in the mammary gland causing a dilution effect on the locally produced
protein, or other physiologic reasons may account for this effect.
Induction of parturition with the low dose oxytocin protocol was also associated with
lower baseline concentrations of AA in the colostrum and milk, although the change
in concentration over time in induced and non-induced mares was similar. It is
unknown what effect, if any, oxytocin would have on the production of this
mammary derived protein, beyond inducing milk let down and diluting the
concentration of AA protein in the milk. However, as the foals begin to nurse and
endogenous hormone is released, the effect of the miniscule amounts of this hormone
required to induce parturition (10 - 20 i.u.) would be obscured.
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Many equine neonatologists promote the withdrawal of enteral feeding from
compromised neonates to avoid overloading the intestine with rich ingesta which may
promote bacterial colonization. Withdrawal of enteral feeding in compromised foals,
however, may result in restriction of access of the beneficial components of
colostrum and milk to the patients that are in most need of them. Recent studies have
focused on the benefits of colostrum to neonates and the vast array of beneficial
components therein that are involved in the protection, growth, development and
maturation of the neonatal intestinal and immune systems and other tissues (12-18).
There has been limited research into the biological factors present in mares’
colostrum and milk (25-28). The milk AA protein has previously been detected in the
colostrum of one mare (3). We now propose that AA protein is present not only in
colostrum but also in the early milk of all mares and is likely to have an important
function in the protection of the neonatal intestine. This protein has been proposed as
a prophylactic treatment for the prevention of gastrointestinal diseases such as
necrotizing enterocolitis and infectious diarrhea in infants (20), conditions that
frequently affect compromised neonatal foals (21-24).
We concluded that AA is present in equine colostrum and early milk. Colostral/milk
AA most likely represents equine milk AA, a mammary gland-derived acute phase
protein identified in bovine, equine, ovine and human colostrum that has been shown
to enhance the innate immune system in the human infant intestine. Given the
relatively high concentrations of the milk AA protein detected in this study in equine
colostrum and also in early milk (which contrasts starkly with bovine milk), further
investigation into the intestinal and systemic effects of this protein and other colostral
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factors in the neonatal foal are warranted to determine the function of colostral
proteins in the health and development of the equine neonate.
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Table 1. Age, breed, gestation, induction, farm of residence and clinical examination
data for all mares
Number Age Breed Gestation Induction Clinical Exam Farm
#1 16 QH 339 No AF for 12hr CVM Ranch
#2 12 QH 338 No Normal CVM Ranch
#3 22 QH 327 No Normal CVM Ranch
#4 9 TB 322 Yes Normal CVM Ranch
#5 13 TB 354 No Normal CVM Ranch
#6 13 QH 354 No Normal CVM Ranch
#7 16 QH No Normal CVM Ranch
#8 12 TB 349 No Normal CVM Ranch
#9 5 TB 354 Yes Normal CVM Ranch
#10 12 Han 356 Yes Normal CVM Ranch
#11 10 TB 366 No Normal CVM Ranch
#12 QH C-section Elective C Section CVM Ranch
#13 5 QH 353 No Retained placenta An. Science
#14 8 QH 343 No Normal An. Science
#15 4 TB 342 Yes Red bag CVM Ranch
#16 8 QH Yes Normal CVM Ranch
#17 7 QH 335 No Normal CVM Ranch
#18 13 QH 342 No Normal An. Science
#19 14 TB 351 No Normal CVM Ranch
#20 8 QH 345 No Retained placenta An. Science
#21 4 QH 338 No Normal An. Science
#22 23 QH 375 No Normal An. Science
#23 15 QH 338 No Normal An. Science
#24 8 TB 343 Yes Normal CVM Ranch
#25 6 TB 339 Yes Normal CVM Ranch
#26 17 TB 331 Yes Normal CVM Ranch
#27 12 TB 343 Yes Normal CVM Ranch
#28 14 TB 353 No Normal CVM Ranch
#29 6 TB 337 No Normal CVM Ranch
#30 20 TB 337 Yes Normal CVM Ranch
#31 15 QH Yes Normal CVM Ranch
#32 6 TB 337 Yes Normal CVM Ranch
#33 10 TB 344 Yes Normal CVM Ranch
#34 QH 338 No Placentitis CVM Ranch
#35 21 QH 335 No Normal An. Science
#36 9 QH 317 No Normal CVM Ranch
#37 11 TB 339 No Mild colic postpartum CVM Ranch
#38 4 TB 340 Yes Mild dystocia CVM Ranch
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Table 2. AA concentrations of maternal serum, colostrum and milk (mcg/ml)
Number Serum Colostrum Milk 12 hr Milk 24 hr Milk 48hr
#1 32.2 134.8 439.1 593.7
#2 69.7 489.2 618.8 688.0 789.4
#3 1.1 441.5 830.9 875.0 922.3
#4 16.0 166.0 907.5 692.6 518.9
#5 17.9 96.1 460.6 401.7 493.2
#6 65.0 173.3 417.6 517.2 452.4
#7 387.7 156.7 683.4 549.1 429.1
#8 0.1 191.6 536.5 464.2 531.9
#9 1.2 285.7 550.6 286.8 307.3
#10 5.6 242.1 307.3 755.3 719.2
#11 1.9 253.8 302.2 230.1 365.6
#12 4.3 21.5 56.9 134.5 72.3
#13 7.7 76.2 90.6 169.5 76.6
#14 6.2 56.2 260.6 224.8 101.1
#15 3.0 13.1 82.0 39.1 125.8
#16 36.0 68.4 145.6 145.8 131.0
#17 6.3 90.2 127.9 231.0 159.3
#18 8.7 42.4 43.8 173.1
#19 11.0 85.6 214.0 140.7 179.6
#20 6.2 30.9 66.2 231.2 285.4
#21 52.2 300.8 133.2 210.7 369.2
#22 8.0 47.7 6.2 261.5 399.5
#23 155.5 191.5 509.0 347.2 754.1
#24 20.5 125.6 280.5 177.5
#25 11.3 95.8 110.4 155.5 121.0
#26 8.2 29.4 74.2 161.6 104.7
#27 8.3 41.7 165.1 62.9 75.1
#28 20.4 93.0 226.6 107.1 41.0
#29 4.9 76.8 190.2 156.8 520.6
#30 14.7 35.8 48.2 115.4 86.1
#31 41.5 205.0
#32 5.8 57.5
#33 25.3 58.7
#34 5.7 81.6
#35 34.6 76.2
#36 69.1 79.4
#37 135.6 966.7
#38 58.0 154.3
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Table 3. AA concentrations of maternal serum at parturition in Thoroughbreds and
Quarter Horses (mcg/ml)
TB Serum AA QH Serum AA
Number Number
#4 16.0 #34 5.7
#5 17.9 #35 34.6
#8 0.1 #36 69.1
#9 1.2 #31 41.5
#11 1.9 #1 32.2
#15 3.0 #2 69.7
#19 11.0 #3 1.1
#24 20.5 #6 65.0
#25 11.3 #7 387.7
#26 8.2 #12 4.3
#27 8.3 #13 7.7
#28 20.4 #14 6.2
#29 4.9 #16 36.0
#30 14.7 #17 6.3
#32 5.8 #18 8.7
#33 25.3 #20 6.2
#37 135.6 #21 52.2
#38 58.0 #22 8.0
#23 155.5
Mean 20.2 Mean 52.5
SD 31.7 SD 89.5
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CHAPTER V
ABSORPTION OF COLOSTRAL AND MILK AMYLOID A IN THE EQUINE
NEONATAL INTESTINE
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Abstract
The objective of this study was to investigate the possibility of neonatal intestinal
absorption of the colostral and milk amyloid A (AA) protein. Nineteen mare-and-
neonatal foal pairs were included in the study. AA concentration was measured in peri-
partum maternal serum, colostrum and early milk samples and in foal serum samples
from birth to 72 hours postpartum. Mean maternal serum concentrations of AA were
consistent with previous studies, although the variation was wide. AA was found in all
colostrum and milk samples and concentrations were consistently higher in the colostrum
and milk than in the peri-partum maternal serum. Foal mean serum AA concentrations
during the post partum period were consistent with those previously described. Colostral
AA concentration was significantly correlated with serum AA concentration in normal
foals at 48 and 60 hours post partum.
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Introduction
Acute phase proteins (APPs) have been detected in the colostrum and milk of many
species (1-3). An isoform of amyloid A (AA) was recently demonstrated in the colostrum
and early milk of women, cows, ewes, sows and one mare (2). This iso-form of amyloid
A, detected in colostrum and milk, called milk amyloid A, is synthesized extra-
hepatically in mammary gland cells. It is produced by healthy animals, expressed by
bovine mammary gland epithelial cells and secreted in abundance as part of a normal
process. In that study the mare colostrum had an AA concentration of 704 mcg/ml.
Concentrations of AA in the colostrum of healthy cows ranged from 89 to 484mcg/ml
and decreased to almost undetectable levels by day 4 post partum. Milk concentrations of
this protein in the mare were not examined in that study.
It has been shown that acute phase proteins in the colostrum of other species are absorbed
into the neonatal circulation (3-5). In the neonatal foal large proteins are absorbed intact
as functional proteins across the intestinal wall (6, 7). Absorption is maximal at about 6
hours after ingestion but increased permeability to macromolecules persists for up to 24
hours. To date there are no studies on the intestinal transfer of colostral or milk APPs in
mares; however, it seems likely that such colostral proteins are absorbed.
Sepsis occurs most commonly in the foal in the first 48 hours of life and the modes of
infection are intrauterine, oral, respiratory and via navel cord or traumatic penetration of
the skin (8). The organisms set up infection in the entry organ. The bacteria and their
toxins invade the blood stream, causing damage to endothelia and the release of cytokine
mediators that initiate the systemic inflammatory response and the increased production
of acute phase proteins. In a study describing the clinico-pathologic features of sepsis in
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foals, the most useful white blood cell parameters were neutropenia and the presence of
band neutrophils (greater than 0.2 X 109/liter) and toxic changes in the neutrophil
population (9). Neutrophil counts of < 2000 cells per ml suggest early overwhelming
infection. Recent work has supported the use of serum AA concentrations in the
differential diagnosis of sepsis in compromised neonatal foals as its concentration
appears to increase dramatically in response to bacterial infection (10). In that study, foal
serum AA concentrations greater than 200 mcg/ml were strongly correlated with sepsis
whereas lower values (20-200 mcg/ml) were suggestive of a non-infective acute phase
response to trauma or pre-maturity (10).
If AA is present in high concentrations in colostrum and milk of mares and absorption of
colostral AA occurs in foals in the first 24 hours of life, it could interfere with the use of
the serum isoform of this protein as an indicator of sepsis in foals, as current assays do
not distinguish the different isoforms. The purpose of this study was to determine
whether absorption of colostral AA in the equine neonatal intestine occurs.
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Materials and Methods
Animals
The study was conducted between January and July 2003. Nineteen pregnant mares in
residence at the Oklahoma State University College of Veterinary Medicine (OSU CVM)
Ranch were used. Sixteen mares were Thoroughbreds and 3 were Quarter Horses (age
range, 4 to 23 yr). There was no evidence of clinical mastitis in any mare. Careful
records were kept in the peri-partum period with regard to clinical conditions, induction
of parturition and complications of parturition. The 19 neonatal foals of the mares were
intensively monitored during the post-partum period.
The low-dose oxytocin protocol (11) was used to induce parturition in a number of the
mares. Calcium concentration in the mammary secretions was used to predict proximity
to parturition. Sampling was initiated 1 wk prior to expected foaling date or if the mare
displayed udder development. Samples were taken daily at 0800 until the calcium
concentration began to rise and then twice daily at 0800 and 1800. When the calcium
concentration was >200 ppm in two samples 24 h apart, parturition was deemed
imminent and the mare could be safely induced.
Before induction, the mare’s tail was wrapped, her perineum was washed with soap and
water, and she was placed in 15 x 25 ft. maternity stall bedded with clean straw.
Parturition was induced with 2.5 i.u. oxytocin (VEDCO, St Joseph, MO, USA) per dose
given IV at 20-min intervals until second stage labor was observed.
Physical examination of the mare and foal was done immediately following parturition
and peri-partum complications were recorded. At 12, 24, 48, and 72 h postpartum,
physical examination of the 18 foals was performed. Sequential complete blood counts
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in the foals at 24, 48 and 72 h were utilized to assess health status. Serum IgG
concentrations in foals at 24 h of age were measured using a commercially available
ELISA (SNAP Foal IgG Test, IDEXX Laboratories, Inc. Westbrook, MN, USA).
For the purposes of examining the influence of AA in the colostrum and milk on serum
concentrations of AA in the foal, the foals were divided into two groups, normal foals
and abnormal foals. A normal foal was defined as one who had an unassisted natural or
induced full-term birth and a normal placenta (i.e. no gross pathological changes), stood
within 2 h and nursed within 3 h after parturition, had an IgG > 4 g/L at 24 h, a neutrophil
count within the normal range (4 to 12 x 109 cells/L) at 24, 48 and 72 h, and had no
clinical signs of disease within the first 7 d. Foals from mares that experienced dystocia,
premature placental separation or placentitis were not included in the group of normal
foals; we speculated that these conditions could affect endogenous serum AA production
in the foal secondary to hypoxia. Only foals whose peri-partum period was closely
monitored and who could beyond doubt fulfill all of the above prerequisites of normality
were included in the investigation of the likelihood of intestinal absorption of this
colostral protein. This was in order to remove any influence of increased endogenous
hepatic-derived AA production (secondary to inflammatory stimuli) on serum AA
concentrations and to isolate the influence of colostral AA, on foal serum AA
concentrations.
Samples
Blood samples were collected into evacuated plain glass tubes from each mare at
parturition and from each neonatal foal prior to colostrum ingestion and at 12, 24, 36, 48,
60, and 72 h postpartum. The foals were gently and carefully restrained to prevent
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traumatic veni-puncture and generation of an inflammatory response associated with the
venipuncture site. Where possible, umbilical cord blood was substituted for the pre-
colostral sample to prevent unnecessary stress associated with venipuncture of the
newborn foal. Blood samples were stored at 4 oC until a clot had formed; they were
subsequently centrifuged at 699 x g for 5 min and the serum was separated and frozen at
–20 oC for later analysis.
Colostrum samples were collected in plain plastic tubes from each mare at parturition.
Milk samples were obtained in plain plastic tubes at 12, 24 and 48 hours post partum
from 30 mares. The colostrum and milk samples were promptly refrigerated and then
stored in a freezer at –20 oC.
Serum AA concentrations
All samples were analyzed for serum AA concentration using Tridelta´s Phase™ Range
SAA assay (Tridelta Limited, Maynooth, Co Kildare, Ireland). This assay has been
previously described in studies that measured colostrum and serum AA concentrations in
clinically normal and diseased horses (12,13). Data are expressed as mcg/mL. On the
first plate, samples were measured in duplicate and thereafter once only. The minimum
detectable concentration of serum AA under the assay was 5 ng/ml. The intra-assay
coefficient of variation was 7.7 and 5.3 at mean serum AA concentrations of 74 and 128
mcg/ml respectively. The inter-assay coefficient of variation was 10.8 and 8.7% at mean
serum AA concentrations of 81 and 134 mcg/ml respectively.
Statistical analysis
The natural log of serum AA, was modeled using a mixed model, fitted using the Mixed
procedure in SAS® v 9.1 (SAS Institute Inc., 2003). A backward selection procedure
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was used to determine an appropriate model; factors remaining significant (p < 0.05)
were retained in the model. The repeated measurements within a foal at different times
were dealt with by including foal as a random effect. The significance of the random
effect was tested by comparing a model excluding the random effect using a likelihood
ratio test. Disease, time and the two-way interaction between these variables were fitted
as fixed effects. Time was checked for linearity by the inclusion of quadratic terms, and
comparing models that included log of time, time as a categorical variable and time as a
continuous variable. Correlation between mare serum and colostrum AA concentration at
parturition and milk AA concentration over the first 48 hours and foal serum AA
concentration during the first 72 hours of life in normal foals was assessed.
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Results
Animals
Nineteen mares and foals were included in the study. One foal was delivered by elective
Caesarian section. Parturition was induced in 11 mares. Seven mares foaled
spontaneously before the 24-h sample was taken. One mare foaled prematurely (317 d)
but the foal was healthy and no complications developed.
Allocation to groups
Of the 19 foals included in the study, 9 were allocated to the normal group.
Abnormalities in the other foals included C-section delivery, prematurity, placentitis,
premature placental separation, dystocia, slowness to nurse, laboratory abnormalities –
subnormal neutrophil counts, clinical suspicion of sepsis,
Normal and abnormal foals and their serum AA concentrations
The mare serum and colostrum AA concentrations and the foal serum AA concentrations
of the normal foals are presented in Table 1. The 9 normal foals had serum AA
concentrations in the previously described range at birth (i.e. from 0.6 to11 mcg/ml)
(Table 1). Over the first 72 hours, however, the serum AA concentrations of these
normal foals varied over a wide range (e.g. at 48 hours they ranged from 4 to 197
mcg/ml). Nonetheless, none of these normal foals had serum AA concentrations in the
previously described septic range (> 200 mcg/ml) although a number of them would have
been considered to be in the range of inflammatory disease (20-200 mcg/ml).
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Statistical analysis
In the analysis of the whole group of 19 foals the random effect of foal was not
significant. The fixed effects, disease and time were both significant (p<0.001) and the 2
way interaction was significant (p < 0.01). Time fitted as a categorical variable gave a
better fitting model compared to when fitted as a continuous, quadratic or logistic
variable.
A significant positive correlation was detected between AA concentration in the
colostrum and in the serum of normal foals at 48 hr (r=0.86, dof=7, p<0.01) and 60 hr (r=
0.83, dof=7, p<0.01) post partum. No correlation was detected between the serum AA
concentrations in the mare at parturition or the AA concentration in the milk from 12
hours and AA concentrations in the serum of normal foals at any time.
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Discussion
The mean and median AA concentrations in the maternal and foal serum at parturition in
this study support previous studies (14, 15) although the variation in maternal serum
sample concentration was wide.
In this study, to minimize the effect of increased endogenous (hepatic) production of
serum AA on the relationship between AA concentrations in colostrum and milk and
subsequently in foal serum, only foals that could be unequivocally confirmed normal
were included in the investigation. There was a significant difference in the serum AA
concentration between the normal foals and the abnormal foals after 12 hours as has been
previously described (10). Therefore, it was reasonable to exclude the abnormal foals
from the assessment of the influence of colostral and milk AA on foal serum AA in the
post-partum period.
A positive correlation between colostrum and foal serum AA concentrations was evident
at 48 and 60 hours post-partum in the normal group of foals. In these foals, no
inflammatory stimulus except the parturition process, common to all the foals, was
thought to be present. It may be appropriate, therefore, to attribute this correlation to
absorption from the intestine as has been shown to occur in other species (3-5). No
correlation was detected between milk AA from 12 hours and subsequent foal serum AA
concentrations at any time. Increased permeability to macromolecules persists for up to
24 hours. Correlation of the milk AA between 12 and 24 hours and subsequent foal serum
AA concentrations may have been masked by the mild post-partum inflammatory
response seen even in normal foals (14).
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We concluded that colostrum AA was absorbed in normal foals. However, given the low
number of normal foals in this study this finding warrants investigation in greater detail.
Further work is indicated to determine whether colostral acute phase proteins are
absorbed in the neonatal foal.
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Table 1. AA concentration in mare serum and colostrum and in the serum of normal foals
(mcg/ml)
Mare
no.
Mare
serum
Colostrum Foal serum
0hr 0hr 0hr 12hr 24hr 36hr 48hr 60hr 72hr
#25 11.3 95.8 7.75 9.53 12.84 12.67 13.70 9.00 10.58
#26 8.2 29.4 7.61 8.11 43.51 23.45 24.43 14.54 12.12
#27 8.3 41.7 6.34 13.18 19.15 20.35 22.20 13.54 12.14
#28 20.4 93.0 11.02 16.78 20.69 21.82 18.31 15.43 16.78
#29 4.9 76.8 4.49 55.37 93.98 95.98 81.60 30.52
#30 14.7 35.8 8.74 6.62 12.38 11.02 15.00 15.14
#31 41.5 205.0 4.27 15.11 20.28 61.66 197.39 53.53 29.15
#32 5.8 57.5 0.57 6.73 19.54 17.08 13.14 11.66 9.20
#33 25.3 58.7 2.79 34.57 5.50 10.92 3.78 0.08 4.27
Mean 15.6 77.1 6.0 18.4 27.5 30.5 43.3 16.6 15.6
SD 11.9 53.5 3.2 16.3 27.0 29.0 62.0 15.7 9.5
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CHAPTER VI
INDUCTION OF PARTURITION IN MARES AND THE NEONATAL ACUTE
PHASE RESPONSE
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Abstract
The objectives of the present study were to determine whether induction of
parturition in mares at term with low doses of oxytocin (2.5 i.u. IV every 20 min)
affected the incidence of peri-partum complications or inflammatory responses in the
neonatal foal. Parturition was induced in 11 of 26 mares and the remainder foaled
spontaneously. Serum concentrations of amyloid A (AA; an acute phase protein)
were measured (with a commercial ELISA) from 0 to 72 h postpartum in 18 of the
neonatal foals. The incidence of dystocia and premature placental separation was
higher in induced mares (2 of 11 and 1 of 11 versus 0 of 15 and 0 of 15, respectively),
whereas retained fetal membranes were more common in spontaneous foalings (2 of
15 versus 0 of 11). When abnormal foals were excluded (to decrease the influence of
endogenous serum AA elevations), serum concentrations of AA increased to the same
extent over time in foals with induced versus spontaneous parturition; foals with
spontaneous parturition had a mean serum AA concentration of 7.8 mcg/ml at birth
that increased to a maximum of 58.9 mcg/ml at 36 h; foals with induced parturition
had a mean serum AA concentration of 5.4 mcg/ml at birth, that increased to a
maximum of 41.4 mcg/ml at 48 h. Baseline serum AA concentrations were lower in
induced foals. We conclude that inducing parturition with low doses of oxytocin in
mares at term did not affect (relative to spontaneous parturition) the temporal
dynamics of serum AA concentrations in the normal foal in the first 72 h of life.
However, the induction procedure may lead to complications during parturition that,
if not detected early, could result in the development of an inflammatory response in
the neonate.
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Introduction
Traditionally it has been considered that there are few clinical indications for
induction of parturition in the mare (1), as it has been associated with an increased
incidence of peri-partum complications such as dystocia, premature placental
separation and with unfavorable outcomes in foals (1-3). Induction of parturition,
however, has a number of potential benefits with regard to mare management,
including controlled attended foaling, decreased incidences of rectal trauma and still-
born foals, and optimized foal outcomes (3). 
The three main methods of inducing parturition in mares are oxytocin, prostaglandin
F2 and dexamethasone. Oxytocin is generally considered the drug of choice (4);
induction of parturition in mares at term with low doses of oxytocin was safe and
reliable, as long as parturition was impending (4). Small doses of oxytocin (2.5 to
10.0 i.u.) effectively triggered parturition in mares at term, whereas higher doses (40
to 120 i.u.) were unnecessary and potentially dangerous (5). Calcium concentrations
of the mammary secretions are useful in predicting full term gestation (6) and are
commonly used to predict impending parturition. Administration of low doses of
oxytocin to full-term mares with calcium concentrations >200 ppm in the mammary
gland secretions for at least 24 h is considered an effective method of inducing
parturition (4). However, the effects on neonatal foals following this induction
protocol have not been thoroughly investigated.
Several studies have examined various parameters in the neonatal foal with regard to
induction of parturition (2,7-9). In one early study describing the induction of mares
with a synthetic prostaglandin, four of eleven foals from induced mares did not
survive to 24 h (2). Although much is now known about how inducing drugs affect
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the mare and methods of induction have been refined from earlier protocols, we are
unaware of any studies that directly address the influence of induction of parturition
on the production of an inflammatory or acute phase response in the foal.
An acute phase protein is a protein with plasma concentrations that increase or
decrease by at least 25% during inflammatory disorders (10). Inflammation causes
the release of cytokines and other inflammatory mediators into the blood. These
mediators act on hepatocytes that are stimulated to synthesize and release acute phase
proteins into the circulation (10). This response can be enhanced by glucocorticoid
production (11). In the horse, serum amyloid A (serum AA) is a major acute phase
protein that appears to increase soon after inflammatory stimuli (12). Serum AA was
greatly elevated (up to five times normal concentrations) in mares 48 h post-partum,
indicating that foaling is an inflammatory process (12). An isoform of serum AA,
milk AA, was recently discovered in the colostrum and early milk of cows, sheep,
mares and women (13); this protein is synthesized in the mammary gland (not in the
liver) and secreted into colostrum and milk.
In two previous reports (12,14), serum AA concentrations in neonatal foals were 23.0
+ 10.7 and 22.2 + 7.6 mcg/ml respectively at 0 h, and were 27.7 + and 26.7 + 16.6
mcg/ml at 72 h (n=12 in both studies). Serum AA concentrations in neonatal foals
increased rapidly in response to inflammatory stimuli, e.g. hypoxic insult, meconium
impaction and sepsis (14,15). In neonatal foals, it was proposed that serum AA
concentrations from 20 to 200 mcg/ml were indicative of inflammatory disease,
whereas concentrations >200 mcg/ml were indicative of sepsis (15). 
The objectives of present study were to determine whether induction of parturition in
mares at term with low doses of oxytocin affected the incidence of peri-partum
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complications or the inflammatory response in the neonatal foal. In that regard, we
documented peri-partum complications associated with induction of parturition and
compared serum AA in newborn foals following induced versus spontaneous
parturition.
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Materials and Methods
Animals
The study was conducted between January and July 2003. Eighteen pregnant mares in
residence at the Oklahoma State University College of Veterinary Medicine (OSU
CVM) Ranch and eight pregnant mares in residence at the OSU Animal Science
Department were used. The 18 neonatal foals of the OSU CVM Ranch mares were
intensively monitored during the post-partum period. Sixteen mares were
Thoroughbreds and 10 were Quarter Horses (age range, 4 to 23 yr).
The low-dose oxytocin protocol (4) was used to induce parturition in a number of the
OSU CVM Ranch mares. Calcium concentration in the mammary secretions was
used to predict proximity to parturition. Sampling was initiated 1 wk prior to
expected foaling date or if the mare displayed udder development. Samples were
taken daily at 0800 until the calcium concentration began to rise and then twice daily
at 0800 and 1800. When the calcium concentration was >200 ppm in two samples 24
h apart, parturition was deemed imminent and the mare could be safely induced. All
eight of the OSU Animal Science Department mares were allowed to foal
spontaneously.
Before induction, the mares’ tails were wrapped, their perineum was washed with
soap and water, and they were placed in stalls bedded with clean straw. Parturition
was induced with 2.5 i.u. oxytocin (VEDCO, St Joseph, MO, USA) per dose given IV
at 20-min intervals until second stage labor was observed.
Physical examination of the mare and foal was done immediately following
parturition and peri-partum complications were recorded. At 12, 24, 48, and 72 h
postpartum, physical examination of the 18 foals was performed. Sequential
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complete blood counts in the foals at 24, 48 and 72 h were utilized to assess health
status. Serum IgG concentrations in foals at 24 h of age were measured using a
commercially available ELISA (SNAP Foal IgG Test, IDEXX Laboratories, Inc.
Westbrook, MN, USA).
For the purposes of examining the effect of parturition on the inflammatory response
in the foal, the foals were divided into two groups, normal foals and abnormal foals.
A normal foal was defined as one who had an unassisted natural or induced full-term
birth and a normal placenta (i.e. no gross pathological changes), stood within 2 h and
nursed within 3 h after parturition, had an IgG > 4 g/L at 24 h, a neutrophil count
within the normal range (4 to 12 x 109 cells/L) at 24, 48 and 72 h, and had no clinical
signs of disease within the first 7 d. Foals from mares that experienced dystocia,
premature placental separation or placentitis were not included in the group of normal
foals; we speculated that these conditions could affect endogenous serum AA
production in the foal secondary to hypoxia.
Samples for serum AA analysis
Blood samples were collected into evacuated plain glass tubes from each mare at
parturition and from each neonatal foal prior to colostrum ingestion and at 12, 24, 36,
48, 60, and 72 h postpartum. The foals were gently and carefully restrained to prevent
traumatic veni-puncture and generation of an inflammatory response associated with
the venipuncture site. Where possible, umbilical cord blood was substituted for the
pre-colostral sample to prevent unnecessary stress associated with venipuncture of the
newborn foal. Blood samples were stored at 4 0C until a clot had formed; they were
subsequently centrifuged at 699 x g for 5 min and the serum was separated and frozen
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at –20 oC for later analysis. Colostrum samples were collected from each mare at
parturition.
Serum AA concentrations
All samples were analyzed for serum AA concentration using Tridelta´s Phase™
Range SAA assay (Tridelta Limited, Maynooth, Co Kildare, Ireland). This assay has
been previously described in studies that measured serum AA concentrations in
clinically normal and diseased horses (13,16). Data are expressed as mcg/ml. On the
first plate, samples were measured in duplicate and thereafter once only. The
minimum detectable concentration of serum AA under the assay was 5 ng/ml. The
intra-assay coefficient of variation was 7.7 and 5.3 at mean serum AA concentrations
of 74 and 128 mcg/ml respectively. The inter-assay coefficient of variation was 10.8
and 8.7% at mean serum AA concentrations of 81 and 134 mcg/ml respectively.
Statistical analysis
Fisher’s Exact tests (two-tailed) were performed to detect difference in incidence of
peri-partum complications in the induced and naturally foaling mares. Student’s t-
tests were used to detect differences between induced and spontaneous parturition
mares for concentrations of serum AA in the serum samples and colostrum at
parturition.
Correlations between the mare serum and colostrum AA concentrations at parturition
and between these concentrations and serum AA concentrations in normal foal serum
over the first 72 h of life were calculated. Only the normal foals were included in this
analysis to eliminate the potential effect of other inflammatory stimuli on foal serum
AA concentration.
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To analyze the differences in foal serum AA concentrations in induced and non-
induced foals, the natural log of serum AA was modeled using a mixed model and
fitted using the Mixed procedure in SAS® v 9.1 (SAS Institute Inc., Cary, NC, USA).
A backward selection procedure was used to determine an appropriate model; factors
remaining significant (P < 0.05) were retained in the model. The repeated
measurements within a foal at different times were handled by including foal as a
random effect. The significance of the random effect was tested by comparing a
model excluding the random effect using a likelihood ratio test. Method of foaling,
time and the two-way interaction between these variables were fitted as fixed effects.
Time was checked for linearity by the inclusion of quadratic terms, and comparing
models that included log of time, time as a categorical variable and time as a
continuous variable. An assessment of the goodness-of-fit was obtained by
examining residuals. Comparisons of means were adjusted using the Tukey
adjustment for multiple comparisons.
The analysis was initially performed on the entire group of 18 foals and then limited
to the group of normal foals (to eliminate the potential effect of other inflammatory
stimuli on an acute phase response).
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Results
Induction
The eight OSU Animal Science Department mares were allowed to foal
spontaneously. Parturition was induced in 11 OSU CVM Ranch mares. Seven OSU
CVM Ranch mares foaled spontaneously before the 24-h sample was taken, making a
total of 15 mares in the study that foaled spontaneously. One OSU CVM Ranch mare
foaled prematurely (317 d) but the foal was healthy and no complications developed.
Peri-partum complications in the mares
Dystocia occurred in 2 of the 11 mares that had parturition induced. In one mare, the
fetus presented normally but the mare did not have abdominal contractions and she
required assistance. In another mare, the foal had unilateral carpal flexion that was
quickly corrected and the foal was delivered without delay. One mare (spontaneous
parturition) had transient postpartum colic that resolved without treatment.
Placentitis was present in one mare with spontaneous parturition and premature
placental separation occurred in another mare in which parturition was induced. Two
mares that foaled spontaneously retained the fetal membranes.
The incidence of dystocia was higher in induced mares (2 of 11 mares versus none of
7 mares). No other difference in incidence of peripartum complications was detected.
Foal outcome
All foals had serum IgG concentrations > 4g/L at 24 h. Nine of the 18 foals were
designated normal (according to our definition) and the other nine were designated
abnormal. Parturition was induced in seven and four of the mares that had normal and
abnormal foals, respectively.
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Abnormalities observed in foals from induced mares
Two foals suffered dystocia. One of these cases of dystocia involved unilateral carpal
flexion (easily corrected and the foal had no further complications). The other
dystocia involved uterine inertia. This foal had a neutrophil count < 4 x 109 cells /L
from 12 to 72 h and was slow to nurse. Two other foals from induced mares had
neutrophil counts < 4 x 109 cells /L from 24 to 72 h; one of these suffered premature
placental separation and was also slow to nurse.
Abnormalities observed in foals from spontaneous parturition mares
One foal was born at 317 d gestation (considered a premature birth); however, the
foal was healthy and showed no evidence of pre-maturity. One foal from a mare with
placentitis developed clinical signs consistent with sepsis and had a neutrophil count
< 4 x 109 cells/L at 24 and 48 h. Two other foals had neutrophil counts < 4 x 109 cells
/L between 24 and 72 h, but no other abnormalities were detected. One additional foal
was slow to nurse, but its laboratory data were normal.
Maternal serum and colostrum AA concentrations
Mean maternal serum AA concentration at parturition was 29.4 mcg/ml. Mean
colostrum AA concentration at parturition was 122.3 mcg/ml. There was no
difference in the change in colostrum and milk AA concentrations over time between
mares that were induced to foal and mares with spontaneous parturition. However,
mares that were induced to foal had lower baseline concentrations of this protein.
Foal serum AA concentrations
In all 18 OSU CVM Ranch foals, mean foal serum AA concentration at birth in the
group of foals from mares that were induced to foal was 6.0 mcg/ml (Table 1). The
concentration increased gradually to a maximum of 139.7 mcg/ml at 72 h. Mean
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pre-colostral foal serum AA concentration in the group of foals from mares that were
not induced to foal (n=7) was 4.6 mcg/ml (Table 1); it increased gradually to a
maximum of 290.1 mcg/ml at 36 h.
When the analysis was limited to the group of normal foals, with no other source of
serum AA stimulation (n=9), mean foal serum AA concentration at birth in the foals
from mares that were induced to foal (n=7) was 5.4 mcg/ml (Table 2). The
concentration increased gradually to a maximum of 41.4 mcg/ml at 48 h. Mean pre-
colostral foal serum AA concentration in the group of normal foals from mares that
were not induced to foal (n=2) was 7.8 mcg/ml (Table 2). The concentration
increased gradually to a maximum of 58.9 mcg/ml at 36 h.
Correlation between maternal and foal AA concentration
In the group of nine normal foals, there was no significant correlation between
maternal serum or colostrum AA concentration and foal serum AA concentration at
parturition. However, there was a positive correlation between colostrum AA
concentration at parturition and foal serum AA at 48 h (r=0.86, dof=7, p<0.01) and 60
h (r=0.86, dof =7, p < 0.01).
Effect of induction on serum AA concentrations in foals over time
In the whole study population of 18 foals, the random effect of foal was not
significant. There was a difference (p<0.001) between the two groups of foals with
regards to method of foaling and time of sampling, however the two-way interaction
was not significant. Time fitted as a categorical variable gave a better fitting model
compared to fitting as a continuous, quadratic or logistic variable. The least-square
mean serum AA for non-induced foals was significantly larger than for induced foals
with means of 54.8 and 18.4 mcg/ml respectively (Table 3). The least-square mean
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serum AA was lower at 0 h compared with at 12 h (P <0.005) and at 0 h compared
with all other times (P < 0.0001); there was no significant difference in the least-
square mean SAA at any other times.
When only normal foals were included in the analysis, the random effect of foal was
again not significant. There was a difference between the two groups of foals with
regards to method of foaling and time of sampling (P = 0.003 and P<0.001
respectively), however the two-way interaction was not significant. Time fitted as a
categorical variable gave a better fitting model compared to fitting as a continuous,
quadratic or logistic variable. The least-square mean serum AA for non-induced foals
was significantly larger than for induced foals with means of 26.9 and 12.0 mcg/ml
respectively (Table 4). The least-square mean serum AA was lower at time 0 h
compared to time 12 h (P< 0.02), at time 0 h compared with 24, 36 and 48 h (p<
0.001) and at time 0 h compared with time 72 h (p<0.03). There was no significant
difference in the least-square mean serum AA at any other times.
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Discussion
This study supported the findings of a previous report (4) that the administration of
low doses of oxytocin in a full term mare with impending parturition (documented by
rising calcium concentration in the mammary secretions) is an effective method of
induction of parturition.
Peripartum complications
Peri-partum complications were noted in both groups of foaling mares. There was a
significantly higher incidence of dystocia in the induced mares compared those with
spontaneous parturition (2 of 11 vs 0 of 15, respectively). Fortunately, in both cases
of dystocia, the attending veterinarian quickly resolved the problem and delivered the
foals. The foal of the mare with inadequate uterine contractions was slow to nurse for
the first time, suggesting mild hypoxic cerebral damage. It is not known if this was
due to the dystocia (that was of short duration), placentitis or premature placental
separation (although there were no indications that the latter two conditions were
present). Decreased neutrophil concentrations, detected between 24 and 72 h in this
foal, were consistent with in utero compromise. Otherwise there were no untoward
consequences in this foal and its IgG concentration was within the normal range by
24 h. The foal of the other mare that suffered dystocia suffered no further untoward
consequences.
Of the 11 mares that had parturition induced, one experienced premature separation
of the placenta (red-bag delivery). None of the 15 mares that foaled naturally
experienced this abnormality. Premature placental separation was one of the more
frequently observed complications of an earlier study in which parturition was
induced with high doses of oxytocin and this was attributed to manual manipulation
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of the fetus (3). In the present study, the fetus was not manually manipulated during
parturition, except for the cases of dystocia in which manipulation occurred only after
the placenta had already ruptured at the cervical star. Induction of parturition was not
significantly associated with the premature placental separation in this study;
however, the occurrence rate (1 in 11) in induced mares seemed higher than that seen
in the normally foaling mare population. In a report from the University of Kentucky
Livestock Disease Diagnostic Centre over a 2 y period from greater than 1300 fetuses
and/or placentae examined per year, only 12 or 13 cases of placental separation
(about 1%) were recorded (17). The actual incidence of this condition is not known
but, in the authors’ experience, is far less than 10% of the normally foaling
population. The foal that suffered placental separation was slightly slow to nurse and
an abnormal neutrophil count was detected from 24 to 72 h. The severity of these
abnormalities suggests that in utero placental compromise due to placentitis or
separation may have occurred, but hypoxic damage to organs secondary to placental
separation during parturition could not be excluded, despite immediate detection and
correction of the abnormality as the chorio-allantoic membrane reached the vulvar
lips and prompt delivery of the foal.
There was a higher incidence of retained fetal membranes in the group of mares that
foaled naturally although this difference was not significant. This may be explained
by the action of oxytocin. Oxytocin stimulates uterine smooth muscle contraction
acting via a typical class 1 G protein-coupled receptor (18). In mares, oxytocin is
used as an uterotonic agent, in the treatment of delayed uterine clearance and retained
fetal membranes. It stimulates contraction of the uterine smooth muscle which is
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believed to aid fluid clearance and release of the fetal membranes from the
endometrium.
There was no increased incidence of uterine rupture, uterine prolapse, failure of
passive transfer, or poor outcome in foals in the group of induced mares.
Maternal AA concentrations
Mean maternal serum AA concentrations were similar to those previously described
(12). AA has been previously detected in the colostrum of one mare at a
concentration of 1,704 mcg/ml (13). There was a wide range of AA concentrations
detected in the colostrum of mares in this study (13 to 967 mcg/ml). Hepatic
production of acute phase proteins is stimulated under the influence of inflammatory
cytokines (10). Milk AA expression is up-regulated in human and bovine mammary
gland cells in response to acute phase stimulants such as lipopolysaccharide and the
lactational hormone, prolactin (19,20). Currently there is insufficient knowledge
regarding the stimulus for colostrum and milk AA synthesis in the mare to explain the
range of colostrum AA concentrations. Further work is warranted to elucidate the
dynamics of mammary derived acute phase proteins in the mare.
There was no difference in serum AA concentrations at birth between the groups of
induced and spontaneously foaling mares. There is a lag period of 16 h after
inflammatory stimulus before serum concentrations of AA rise above normal (21). If
induction of parturition had an effect on serum AA concentration it would not be
apparent until at least 16 h after induction. Maternal serum AA concentration was not
measured at this time. Mares that were induced to foal had lower baseline AA
concentrations in the colostrum and milk although the change in concentration over
time was not different. The dynamics of colostrum AA production are not clearly
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understood; therefore, it is unknown how long it would take for any potential effect
of induction on colostrum AA concentration to take effect. This needs to be
investigated in more detail.
Foal AA concentrations
Serum AA concentrations in the neonatal foals in this study were consistent with
previously reported values (Table 1) (12,14). In normal foals, there is a mild increase
in serum AA concentrations early in life (12,14). As the stimulus for hepatic derived
AA production is the release of cytokines from damaged tissue, this mild increase in
foal serum AA concentrations in normal foals in the early neonatal period is likely
attributable to mild intra-partum tissue damage enhanced by glucocorticoid release as
part of the birth process. The possible etiology of intra-partum fetal tissue damage
might include normal events such as separation of the placenta from the
endometrium, rupture of the chorio-allantois and tearing of the umbilicus. As the
placental blood continues to supply the fetus until the umbilicus separates, cytokines
released during these events could potentially reach and stimulate fetal hepatic cells.
The effects might be localized enough to produce the mild inflammatory response
evidenced by the slight raise in normal foal serum AA after birth, but would not
produce the serum AA concentration increase evident with systemic disease.
Correlation of maternal and foal AA concentration
The lack of correlation of maternal and fetal serum AA concentrations at birth
supported the acknowledged minimal transport of proteins, such as AA, across the
equine placenta (22) and the presence of individual endogenous inflammatory
response systems in the dam and fetus. In addition, inflammatory cytokines, which
might stimulate acute phase protein production, do not cross the endotheliochorial
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placenta in humans (23) and are unlikely to cross the more complex epitheliochorial
equine placenta from dam to fetus.
The correlation between colostrum AA concentration and normal foal serum AA
concentration at 48 h suggested intestinal absorption of the colostral protein in the
postnatal period of macromolecular absorption in the foal. Although the colostrum
intake was not quantified, all foals nursed adequately and had IgG concentrations
within an acceptable range by 24 h, indicating adequate colostral absorption. Foal
neonatal intestinal cells are thought to be non-selective in the uptake of
macromolecules during this period (24,25) therefore it is not unreasonable to suggest
that absorption of this colostral protein does occur.
Peri-partum complications and foal serum AA concentration
We inferred that the induction of parturition may predispose to dystocia and an
increased inflammatory response in the foal. One of the two foals that experienced
dystocia developed a high serum AA concentration (Mare P). This foal was not mal-
positioned but it required assistance because the mare did not have adequate uterine
contractions. This foal developed a low neutrophil count from 24 to 72 h; whether
this was attributable to the dystocia and subsequent hypoxic tissue damage and
inflammation or to in utero events was unclear. The foal that was mal-positioned
(unilateral carpal flexion) did not develop a high serum AA concentration, nor was its
neutrophil count outside the normal range at any observed time. Perhaps the dystocia
was more severe in the first case; however, in neither case was the birth prolonged as
the dystocia was corrected quickly and the foals delivered.
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Induction of parturition and foal serum AA concentrations
This study examined the inflammatory response in the foal over the first 72 h of life
following induction of parturition with low doses of oxytocin in the term mare. To
eliminate the effect of extraneous inflammatory events of serum AA concentrations in
the population of foals in the study, in addition to assessing the whole study
population of foals, we also assessed the subpopulation of normal foals with no
extraneous inflammatory conditions, as a more accurate way to isolate the effect of
induction on the inflammatory response.
Foals from mares in which parturition was induced did not exhibit an increased
inflammatory response beyond that which results from the natural birthing process,
either in the whole group of foals or in the sub-population of normal foals. The
effects of differences in the birth process on foal serum AA would not be evident
until at least 16 h post partum given the lag period (21). Therefore the response was
measured over the first 72 h of life. There was no difference in the response over time
between the two groups of foals, i.e. the change in serum AA concentration over time
in both groups was not significantly different.
There were lower baseline serum AA concentrations over time in the foals that were
induced. It is difficult to explain why the induced foals had lower baseline serum AA
concentrations measurements than the foals that were not induced. Perhaps this could
be attributed to absorption of colostral AA, as maternal colostrum concentrations of
AA were lower in induced than non-induced mares.
The mares in this study that foaled naturally did so before they could be induced, i.e.
once their milk calcium concentration reached 200 ppm but before two samples 24 h
apart could be collected. Although the relationship between fetal cortisol production
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and parturition is not yet clear in the foal, perhaps there was a higher concentration of
circulating fetal corticosteroids in these foals leading to enhanced serum AA
production. Indeed perhaps serum AA concentrations in the post partum foal could be
an indicator of “readiness for birth”. Comparison of serum AA concentrations at
birth in premature/dysmature and mature foals should be assessed in the future to
determine the effectiveness of this inflammatory protein as a marker of maturity.
It is unclear whether oxytocin may have some direct effect on the production of
serum AA. Oxytocin receptors have been identified in many tissues, including the
kidney, heart, thymus, pancreas, and adipocytes (26). In addition to the well known
effects of oxytocin on uterine contraction and milk ejection oxytocin may also modify
blood pressure and heart rate both through effects within the CNS and through effects
in other organs, such as the heart, blood vessels and kidney (27). Oxytocin may have
as yet unrecognized effects on the parturient foal.
It should be borne in mind, also, that the increase in serum AA concentrations in
normal foals after natural birth may have protective effects in the neonatal foal. The
exact functions of serum AA in the circulation have yet to be elucidated although
they are proposed to be involved in lipid metabolism/transport, induction of extra-
cellular-matrix-degrading enzymes, and chemotactic recruitment of inflammatory
cells to sites of inflammation (11). Therefore the lower serum AA concentrations in
induced foals may have a detrimental effect on neonatal viability. Further study is
necessary to elaborate these findings.
In conclusion, induction of parturition at term with a low-dose oxytocin protocol was
associated with a higher incidence of dystocia, but with a lower incidence of retention
of fetal membranes. It did not induce an inflammatory response in the foal over time
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in excess of that in foals with spontaneous parturition. This method of induction
ensured an observed parturition and provided a controlled environment whereby
potential problems and complications were readily identified and corrected. It must
be emphasized that this induction protocol should followed strict indications for
induction of parturition and that experienced personnel should be available to detect
and correct any complications.
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Table 1. Concentrations of amyloid A in the serum and colostrum of all 18 mares and
in the serum of their foals (mcg/ml)
Mare
Parturition Mare
serum
Colostrum Foal serum
0 h 0 h 0 h 12 h 24 h 36 h 48 h 72 h
A Spontaneous 4.9 76.8 4.5 55.4 94.0 96.0 81.6 30.5
B Spontaneous 69.1 79.4 0.6 12.6 43.4 39.5 28.2 32.8
C Spontaneous 135.6 966.7 2.3 323.8 262.4 406.8 373.0 239.8
D Spontaneous 20.4 93.0 11.0 16.8 20.7 21.8 18.3 16.8
E Spontaneous 6.3 90.2 3.7 69.8 315.2 432.2 510.3 221.9
F Spontaneous 5.8 81.6 2.1 124.5 744.6 744.6 744.6 723.4
G Spontaneous 11.0 85.6 7.8 24.4 74.7 - 60.3 31.7
Mean 36.2 210.5 4.6 89.6 222.1 290.1 259.5 185.3
SD 49.4 333.5 3.7 110.4 256.2 287.4 287.0 256.0
H Induced 14.7 35.8 8.7 6.6 12.4 11.0 15.0 -
I Induced 8.2 29.4 7.6 8.1 43.5 23.4 24.4 12.1
J Induced 11.3 95.78 7.8 9.5 12.8 12.7 13.7 10.6
K Induced 8.3 41.7 6.3 13.2 19.2 20.4 22.2 12.1
L Induced 25.3 58.7 2.8 34.6 5.5 10.9 3.8 4.3
M Induced 5.75 57.5 0.6 6.7 19.5 17.1 13.1 9.2
N Induced 41.5 205.3 4.3 15.1 20.3 61.7 197.4 29.1
O Induced 58.0 154.3 7.0 5.0 4.5 6.0 5.7 5.0
P Induced 20.5 125.6 6.0 28.9 215.5 363.2 457.5 395.0
Q Induced 36.0 68.4 10.9 10.3 14.3 48.4 412.3 851.1
R Induced 3.0 13.1 3.9 22.5 133.8 185.3 191.1 68.1
Mean 21.1 80.5 6.0 14.6 45.6 69.1 123.3 139.7
SD 17.5 59.2 2.9 9.9 67.2 110.3 170.1 277.2
Prob.a 0.4 0.35
aProb. = probability of a difference between spontaneous and induced parturition.
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Table 2. Concentrations of amyloid A in the serum and colostrum of mares of normal
foals and in the serum of the foals (mcg/ml)
Mare
Parturition Mare
serum
Colostrum Foal serum
0 h 0 h 0 h 12 h 24 h 36 h 48 h 72 h
A Spontaneous 4.9 76.8 4.5 55.4 94.0 96.0 81.6 30.5
D Spontaneous 20.4 93.0 11.0 16.8 20.7 21.8 18.3 16.8
Mean 12.7 84.9 7.8 36.1 57.3 58.9 50.0 23.6
SD 11.0 11.5 4.6 27.3 51.8 52.4 44.8 9.7
H Induced 14.7 35.8 8.8 6.6 12.4 11.0 15.0 -
I Induced 8.2 29.4 7.6 8.1 43.5 23.5 24.4 12.1
J Induced 11.3 95.78 7.7 9.5 12.8 12.7 13.7 10.6
K Induced 8.3 41.7 6.3 13.2 19.2 20.4 22.2 12.1
L Induced 25.3 58.7 0.6 6.7 19.5 17.1 13.1 9.2
M Induced 5.75 57.5 2.8 34.6 5.5 10.9 3.8 4.3
N Induced 41.5 205.3 4.3 15.1 20.3 61.7 197.4 29.2
Mean 16.4 74.9 5.4 13.4 19.0 22.4 41.4 12.9
SD 12.8 61.5 3.0 9.9 12.0 17.9 69.1 8.5
Prob.a 0.7 0.7
aProb. = probability of a difference between spontaneous and induced parturition.
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Table 3: Least square means and 95% confidence intervals of serum amyloid A
concentrations (mcg/ml) for the entire group of 18 foals. (LSM for spontaneously
delivered foals was different from that of induced foals (p< 0.001). LSM at time 0 was
different from time 12 (p< 0.005) and from all other times (p< 0.0001))
Variable Value Least-
square
mean
95% confidence interval
Lower Upper
Method Spontaneous 54.8 36.4 82.4
Induced 18.4 13.3 25.5
Time 0 4.7 2.5 8.8
12 23.7 12.8 44.0
24 48.0 25.9 89.1
36 61.3 32.4 116.1
48 66.9 36.1 124.1
72 46.4 24.6 87.6
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Table 4. Least square means and 95% confidence intervals for serum amyloid A
concentrations (mcg/ml) for the nine normal foals. (LSM for spontaneously delivered
foals was different from that of induced foals (p< 0.003). LSM at time 0 was different
from time 12 (p< 0.02), from times 24 to 48 (p<0.001) and from time 72 (p< 0.05))
Variable Value Least-
square
mean
95% confidence interval
Lower Upper
Method Spontaneous 26.9 17.2 42.2
Induced 12.0 9.4 15.4
Time 0 5.9 3.4 10.0
12 17.6 10.3 30.2
24 25.3 14.7 43.3
36 28.4 16.6 48.6
48 28.4 16.6 48.7
72 16.1 9.2 28.4
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